Sequelae of external causes of morbidity and mortality

VWXY20_SEQUEL_EXTER_CAUSES_MORBIDI_MORTA

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Y85-Y89 Cause of death: ICD-10 — Y85-Y89 2 out of 7 registries used, show all original rules.	13833
4. Check minimum number of events None	13833
5. Include endpoints VWXY20_SEQUEL_TRANSPO_ACCIDENTS VWXY20_SEQUEL_OTHER_ACCIDENTS VWXY20_SEQUEL_INTENTI_SELF_H_ASSAU_EVENTS_UNDET_INTENT VWXY20_SEQUEL_W_SURGI_MEDICAL_CARE_EXTER_CAUSE VWXY20_SEQUEL_OTHER_EXTER_CAUSES	13833
6. Filter based on genotype QC (FinnGen only)	12393

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: V|W|X|Y

NAME	VWXY20_SEQUEL_EXTER_CAUSES_MORBIDI_MORTA
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	VWXY20_SEQUEL_TRANSPO_ACCIDENTS\|VWXY20_SEQUEL_OTHER_ACCIDENTS\|VWXY20_SEQUEL_INTENTI_SELF_H_ASSAU_EVENTS_UNDET_INTENT\|VWXY20_SEQUEL_W_SURGI_MEDICAL_CARE_EXTER_CAUSE\|VWXY20_SEQUEL_OTHER_EXTER_CAUSES
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Y8[5-9]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Y8[5-9]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sequelae of external causes of morbidity and mortality based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	12393	6852	5541
Unadjusted period prevalence (%)	2.48	2.43	2.54
Median age at first event (years)	64.14	61.69	67.19

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12825: Matched controls
128250

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Y89

ICD-10 Finland

Sequelae of other external causes

1054.3

316.7

309

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

15.5

315.6

275

181

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

313.9

6993

47963

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.3

309.5

1252

4027

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.2

309.3

3493

18659

WX320

NOMESCO Finland

Spinalanesthesy

2.5

307.7

4248

21489

TPH07

NOMESCO Finland

Cathetrisation of artery

2.8

307.7

2180

8664

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

5.2

307.7

1350

2841

N03AX12

ATC

[U] gabapentin; oral

2.5

307.7

2744

12600

Y88.1

ICD-10 Finland

Sequelae of misadventures to patients during surgical and medical procedures

9115.0

307.7

2291

Y86

ICD-10 Finland

Sequelae of other accidents

3249.5

307.7

639

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

307.7

4067

21964

T84.8

ICD-10 Finland

Other complications of internal orthopaedic prosthetic devices, implants and grafts

31.3

307.7

258

NGC30

NOMESCO Finland

Secondary implantation of prosthesis in knee joint, special prosthesis

25.4

307.7

433

176

S97

ICPC

Chronic ulcer skin

3.3

307.7

1353

4377

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

13.0

307.7

777

633

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

10.5

307.7

370

363

X58

ICD-10 Finland

Exposure to other specified factors

2.7

307.7

2628

11367

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.7

307.7

989

1573

N02AA05

ATC

oxycodone; systemic

2.4

307.7

3185

15579

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

7.1

307.7

908

1365

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

307.7

2895

13975

T81.9

ICD-10 Finland

Unspecified complication of procedure

8.1

307.7

656

844

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

31.0

307.7

1337

480

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.4

307.7

1674

5363

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.1

307.7

6375

41657

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

15886.1

307.7

1425

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

3.0

307.7

2203

8397

ZXD05

NOMESCO Finland

Urgent procedure

2.6

307.7

5126

25942

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.0

307.7

831

1472

M16.1

ICD-10 Finland

Other primary coxarthrosis

3.2

307.7

2508

9115

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

3.5

307.7

1617

5137

ZXA00

NOMESCO Finland

Right side

2.2

307.7

4106

22509

B01AB05

ATC

enoxaparin; parenteral

3.2

307.7

6123

28394

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

8.3

307.7

881

1132

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

24.2

307.7

2698

1397

N03AX16

ATC

[U] pregabalin

2.4

307.7

3836

19404

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7.0

307.7

2482

4263

J01FF01

ATC

clindamycin; systemic

2.3

307.7

4274

23254

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

16384.0

307.7

6058

J04AB02

ATC

rifampicin; systemic

13.7

307.7

621

475

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

7.4

307.7

562

787

ZXA05

NOMESCO Finland

Left side

2.2

307.7

3859

20704

J01XX08

ATC

linezolid; systemic

14.0

307.7

299

218

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

7.2

307.7

2311

3780

WX402

NOMESCO Finland

General anaesthesia

2.5

307.7

3880

18879

TQW11

NOMESCO Finland

Vacuum treatment of wound

6.3

307.7

641

1066

NFH30

NOMESCO Finland

Reduction of dislocation prosthesis of hip joint, closed

22.8

307.7

376

170

T84.1

ICD-10 Finland

Mechanical complication of internal fixation device of bones of limb

15.3

307.7

352

236

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.4

307.7

2744

12890

NGC20

NOMESCO Finland

Secondary implantation of prosthesis in knee joint, normal prosthesis

31.9

307.7

375

121

ZZH31

NOMESCO Finland

Bone allograft, small pieces

12.0

307.7

330

282

S18

ICPC

Laceration/cut

2.3

307.7

7361

46960

NGC00

NOMESCO Finland

Exchange of a loose part of prosthesis in knee joint

28.2

307.7

370

135

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

30.8

307.7

1197

427

NFC40

NOMESCO Finland

Repair of hip prosthesis by bone transplant to acetabulum

26.6

307.7

309

119

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.2

307.7

1198

3075

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.8

307.7

2691

11135

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

6.6

307.7

582

915

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.7

307.7

2406

10131

ZXE10

NOMESCO Finland

More than one and less than three hours

2.3

307.7

5613

32074

S73.0

ICD-10 Finland

Dislocation of hip

17.0

307.7

342

206

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.2

307.7

5094

29159

9294

FHL

Endoprosthesis replacement of the entire hip joint (eg Charnley)

13.2

307.7

346

269

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

4.0

307.7

1577

4381

NF1AA

NOMESCO Finland

Hip X-ray examination

3.3

307.7

2000

6805

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

10.6

307.7

4912

7096

N02AX02

ATC

tramadol; systemic, rectal

2.5

307.7

6910

41269

Y88.0

ICD-10 Finland

Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use

280.5

307.7

328

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

5855.4

307.7

2028

X59

ICD-10 Finland

Exposure to unspecified factor

3.2

307.7

3919

15437

ZXE20

NOMESCO Finland

More than three and less than five hours

2.9

307.7

2476

9929

NFC00

NOMESCO Finland

Exchange of a loose part of prosthesis in hip joint

28.8

307.7

369

132

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

307.5

3537

19025

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

305.7

3081

15704

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

302.2

6193

41070

WX002

NOMESCO Finland

Sedation and analgesia

2.3

302.1

3081

15772

N02BE01

ATC

paracetamol; systemic, rectal

3.5

297.4

11988

102809

NFU00

NOMESCO Finland

Removal of partial prosthesis from hip joint, other or unspecified

73.2

294.9

159

J01DB01

ATC

cefalexin; oral

2.6

292.1

11111

91811

B01AB10

ATC

tinzaparin; parenteral

2.6

281.2

1928

8249

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.4

279.8

2251

10371

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

4.0

279.4

847

2245

M79.6

ICD-10 Finland

Pain in limb

1.9

276.7

6291

42771

NGU00

NOMESCO Finland

Removal of partial prosthesis from knee joint, other or unspecified

64.1

276.1

152

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.8

266.5

1473

5645

C03CA01

ATC

furosemide; systemic

2.0

265.2

4553

28077

A46

ICD-10 Finland

Erysipelas

2.3

262.9

2469

12135

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.3

256.7

2396

11733

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.9

255.4

1296

4738

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.0

253.1

1209

4273

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

252.0

2016

9230

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

251.7

2218

10593

ZXE00

NOMESCO Finland

One hour or less

1.9

248.3

5336

35234

M96.6

ICD-10 Finland

Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate

12.1

246.2

247

207

J01MA12

ATC

levofloxacin; systemic

2.1

245.8

2853

15214

A02BC02

ATC

pantoprazole; systemic

2.0

242.0

9269

73211

J01MA02

ATC

ciprofloxacin; systemic

1.9

241.2

5485

36772

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

237.2

5739

39163

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

4.7

235.5

555

1211

NGC60

NOMESCO Finland

Exchange or addition of patellar part

14.4

232.9

211

149

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

229.8

1800

8140

L13

ICPC

Hip symptom/complaint

2.0

229.0

2988

16588

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

227.5

2905

15995

NGC99

NOMESCO Finland

Other secondary prosthetic replacement inknee joint, other or unspecified

23.5

222.6

160

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

222.3

9393

75380

NFU20

NOMESCO Finland

Removal of internal fixation device from femur

8.5

221.6

288

346

R4110

NOMESCO Finland

Physiotherapy

1.9

220.8

3994

24738

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.7

218.9

1262

4922

ZZA00

NOMESCO Finland

Split skin graft

4.1

217.3

616

1551

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

6.8

217.1

343

515

A28

ICPC

Limited function/disability NOS

2.0

213.4

2801

15532

SPAT1153

SPAT

Removal of sutures

1.8

211.3

4394

28350

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.5

207.7

1502

6534

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.9

206.2

625

1651

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

205.1

1830

8727

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.9

204.8

1010

3621

L28

ICPC

Limited function/disability (L)

2.0

203.4

2918

16658

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.6

202.7

696

2003

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

4.1

201.3

578

1468

7151E

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, LONKKANIVEL]

9.0

200.2

249

283

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.3

197.3

767

2390

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

6.1

196.5

348

587

WX212

NOMESCO Finland

Femoral plexus blockade

4.2

196.3

545

1350

H02AB06

ATC

prednisolone; systemic

1.7

194.5

6421

47029

B01AB04

ATC

dalteparin; parenteral

3.0

192.6

923

3253

AA1AD

NOMESCO Finland

CT of head and brain

1.8

191.0

4131

26792

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

188.0

1584

7355

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.7

186.3

626

1774

B01AX06

ATC

[U] rivaroxaban

4.3

184.9

488

1163

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

184.2

2414

13298

NFH10

NOMESCO Finland

Reduction of dislocation of hip joint, closed

21.1

184.1

138

R50.9

ICD-10 Finland

Fever, unspecified

2.0

179.1

2240

12123

NGW10

NOMESCO Finland

Reoperation for deep infection in in surgery of knee or lower leg

44.5

179.1

106

T88.9

ICD-10 Finland

Complication of surgical and medical care, unspecified

11.7

176.3

181

157

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

172.8

4032

26567

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

5.5

172.6

340

634

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

172.1

5012

35097

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.8

171.7

535

1439

W19

ICD-10 Finland

Unspecified fall

2.2

171.3

1554

7427

Y87.1

ICD-10 Finland

Sequelae of assault

844.7

170.3

167

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

3.2

170.2

714

2327

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

169.8

4924

34409

N06AX21

ATC

duloxetine; oral

2.1

169.2

1755

8845

T84.4

ICD-10 Finland

Mechanical complication of other internal orthopaedic devices, implants and grafts

17.8

168.2

136

NF3AA

NOMESCO Finland

Femur X-ray examination

4.1

167.2

471

1178

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

3.7

166.1

539

1491

NFJ62

NOMESCO Finland

Internal fixation of fracture of other parts of femur with plate

7.9

164.4

227

293

Y89.1

ICD-10 Finland

Sequelae of war operations

+∞

163.9

157

NFB50

NOMESCO Finland

Primary total prosthetic replacement of hip joint using cement

5.0

163.8

357

728

NFW10

NOMESCO Finland

Reoperation for deep infection in in surgery of hip or thigh

33.5

161.6

103

J01CF05

ATC

flucloxacillin; systemic

2.5

161.0

1134

4849

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

159.8

4578

31751

Z3226

NOMESCO Finland

Physiotherapist

1.9

159.2

2487

14459

NFJ64

NOMESCO Finland

Other internal fixation of fracture of other parts of femur

13.8

158.5

147

108

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

155.3

4812

34000

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.4

155.2

1119

4833

Y85.0

ICD-10 Finland

Sequelae of motor-vehicle accident

1556.9

154.4

150

N02BF02

ATC

pregabalin; oral

2.5

154.1

1097

4710

NFS10

NOMESCO Finland

Incision and debridement of infection of hip joint

31.5

154.1

100

R06.0

ICD-10 Finland

Dyspnoea

1.7

152.1

3730

24742

N06AX11

ATC

mirtazapine; oral

1.7

151.5

4491

31319

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

2.4

148.9

1130

4991

A02BC01

ATC

omeprazole; systemic

1.7

146.9

3611

23924

SPAT1255

SPAT

Intravenous administration of medicine

2.4

146.6

1071

4649

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.1

146.1

410

1022

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.8

145.0

764

2826

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

144.5

3743

25129

P01AB01

ATC

metronidazole; oral, rectal

1.6

143.8

5047

36595

WZC30

NOMESCO Finland

Teaching

1.9

143.8

2338

13719

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

143.2

1764

9432

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

5.4

142.9

286

541

Y96.9

ICD-10 Finland

Unspecified type of accident

4.2

142.5

393

967

L17

ICPC

Foot/toe symptom/complaint

1.7

142.1

4148

28700

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

142.0

3529

23409

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.3

139.9

1168

5370

L15

ICPC

Knee symptom/complaint

1.7

138.9

3406

22489

JN4AD

NOMESCO Finland

Body CT examination

2.0

138.4

1726

9263

A02BC05

ATC

esomeprazole; systemic

1.6

137.9

5216

38396

UJF32

NOMESCO Finland

Coloscopy

1.7

137.9

3532

23585

NFC99

NOMESCO Finland

Other secondary prosthetic replacement in hip joint, other or unspecified

16.2

137.8

117

M48.0

ICD-10 Finland

Spinal stenosis

2.0

137.8

1803

9837

C07AB07

ATC

bisoprolol; oral

1.6

136.9

6315

48679

M25.5

ICD-10 Finland

Pain in joint

1.6

136.6

4244

29762

N02BF01

ATC

gabapentin; oral

2.1

136.6

1534

7925

T84.9

ICD-10 Finland

Unspecified complication of internal orthopaedic prosthetic device, implant and graft

16.8

135.6

113

B01AF01

ATC

rivaroxaban; oral

1.9

135.4

1837

10142

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.2

135.4

365

883

WX213

NOMESCO Finland

Lower leg blockade

6.2

135.1

231

376

NG1DA

NOMESCO Finland

X-ray of knees

4.2

134.3

367

897

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

133.8

1904

10678

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.5

133.5

881

3644

N05CF01

ATC

zopiclone; oral

1.6

133.2

4172

29272

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

133.2

1921

10821

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

6.1

133.1

232

385

NG1AD

NOMESCO Finland

Knee CT examination

4.4

132.9

340

790

M01AH05

ATC

etoricoxib; oral

1.6

130.2

7717

62705

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.5

130.2

860

3558

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.0

129.8

1480

7680

NHQ40

NOMESCO Finland

Amputation of toe

4.4

129.3

334

782

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.9

128.8

639

2286

WX702

NOMESCO Finland

Supraglottic ventilation device

2.5

128.3

869

3637

NGS10

NOMESCO Finland

Incision and debridement of infection of knee joint

13.1

127.0

121

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

126.7

1403

7200

TQW40

NOMESCO Finland

Remowal of suture of skin

2.3

125.3

1055

4860

WX400

NOMESCO Finland

Inhalation anesthesy

2.8

125.0

641

2334

L89

ICPC

Osteoarthrosis of hip

2.8

124.8

641

2336

JAH00

NOMESCO Finland

Laparotomy

3.3

124.5

487

1518

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

5.7

124.1

232

412

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

123.5

1495

7918

S72.0

ICD-10 Finland

Fracture of neck of femur

2.8

122.6

652

2420

Z3231

NOMESCO Finland

Registered nurse

1.6

122.3

3494

23860

M54.5

ICD-10 Finland

Low back pain

1.6

122.1

4661

34106

A01

ICPC

Pain general/multiple sites

2.0

122.1

1466

7740

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

2.8

121.7

653

2435

NHG20

NOMESCO Finland

Fusion of talocrural joint

7.1

121.4

182

258

WX892

NOMESCO Finland

Monitored bed care

2.2

121.1

1109

5286

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.6

120.9

402

1129

R60.0

ICD-10 Finland

Localized oedema

1.9

120.7

1831

10456

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.3

120.2

981

4458

A06AD11

ATC

lactulose; oral

1.8

120.0

2011

11845

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.1

119.1

1261

6357

R52.2

ICD-10 Finland

Other chronic pain

2.8

118.5

619

2275

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

118.3

1188

5868

ZXA10

NOMESCO Finland

Bilateral

1.7

118.1

2432

15209

NFF20

NOMESCO Finland

Cleaning of hip joint, open

65.3

118.1

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

118.0

3116

20827

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.2

117.2

200

325

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

115.4

2982

19801

SPAT1263

SPAT

Sampling

1.5

113.6

5211

39545

T90.5

ICD-10 Finland

Sequelae of intracranial injury

5.1

113.4

243

488

SPAT1301

SPAT

No procedures

1.6

113.1

3983

28487

L90

ICPC

Osteoarthrosis of knee

2.2

112.2

1030

4908

Z71.8

ICD-10 Finland

Other specified counselling

1.6

112.1

4314

31467

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

110.3

6426

51186

M01AH01

ATC

celecoxib; oral

1.7

110.1

2295

14371

S72.3

ICD-10 Finland

Fracture of shaft of femur

5.4

109.4

217

407

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

108.7

1923

11482

N05AH04

ATC

quetiapine; oral

1.7

108.4

2205

13707

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

108.3

3632

25633

L70

ICPC

Infection of musculoskeletal system

7.9

107.7

148

190

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

106.9

1019

4926

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.6

106.7

358

1011

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.5

106.6

720

3004

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

106.3

916

4251

WX704

NOMESCO Finland

Intubation

2.1

105.5

1153

5870

X57

ICD-10 Finland

Unspecified privation

3.3

105.4

399

1218

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.2

105.1

909

4225

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.5

104.8

666

2700

SPAT1229

SPAT

Assessment of need for aid

2.1

104.6

1093

5472

T84.62

ICD-10 Finland

Osteitis associated with dental implants

6.4

104.0

173

274

NF1DA

NOMESCO Finland

X-ray of hips

3.4

103.7

385

1161

N06AX16

ATC

venlafaxine; oral

1.8

103.2

1764

10413

TK800

NOMESCO Finland

Hemodialysis

3.5

102.6

366

1076

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

102.3

2903

19643

QX4YT

NOMESCO Finland

Puncture of superficial collection under ultrasound guidance

8.9

102.2

127

144

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

101.3

2306

14749

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.6

101.3

591

2297

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.8

100.9

526

1930

NGU20

NOMESCO Finland

Removal of internal fixation device from knee or lower leg

3.8

100.6

316

853

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

100.6

7732

64626

M01AH02

ATC

rofecoxib; oral

1.8

100.4

1646

9588

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

100.1

1587

9151

A41.9

ICD-10 Finland

Sepsis, unspecified

2.7

100.1

562

2143

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.9

99.7

472

1644

QDB10, ,

SPAT

3.0

99.5

442

1485

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.7

99.4

550

2081

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

99.2

2102

13181

WZA00

NOMESCO Finland

Concise certificate

2.2

99.0

893

4220

B01AX05

ATC

fondaparinux; parenteral

5.5

98.2

189

345

NFB60

NOMESCO Finland

Demanding prosthetic replacement of hip

7.6

98.1

139

185

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.4

98.1

359

1073

N06AA09

ATC

amitriptyline; systemic

1.9

97.5

1262

6811

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

97.4

4671

35439

Y84.9

ICD-10 Finland

Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.5

96.6

158

246

R03AC02

ATC

salbutamol; inhalant

1.5

96.5

6660

54280

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

96.3

1990

12383

NH1AD

NOMESCO Finland

Ankle and foot CT

3.2

96.3

390

1241

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

3.0

96.2

439

1497

ZX120

NOMESCO Finland

Intravenous

1.9

96.2

1244

6710

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

5.3

95.4

195

376

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

95.2

1063

5446

T78.4

ICD-10 Finland

Allergy, unspecified

2.5

95.2

634

2626

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

95.1

8043

68126

T81.7

ICD-10 Finland

Vascular complications following a procedure, not elsewhere classified

9.4

95.0

113

121

WX725

NOMESCO Finland

Noninvasive ventilation

2.3

94.8

801

3684

NFC30

NOMESCO Finland

Repair of hip prosthesis by bone transplant to femur

17.8

93.9

L01BA01

ATC

methotrexate; systemic

2.6

93.7

547

2126

T88.8

ICD-10 Finland

Other specified complications of surgical and medical care, not elsewhere classified

7.1

93.2

140

199

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.4

93.1

699

3056

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.2

93.0

846

4008

XX3DW

NOMESCO Finland

Time consuming IT work

1.9

92.8

1415

8049

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

3.2

92.7

375

1192

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

92.3

3194

22551

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

91.4

638

2699

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

91.1

1269

7010

NGQ20

NOMESCO Finland

Amputation of lower leg

7.0

91.1

138

198

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.7

91.0

492

1839

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

90.5

2802

19275

N05BA04

ATC

oxazepam; oral

1.5

90.3

3240

23038

J01CA04

ATC

amoxicillin; systemic

1.6

90.2

10045

89495

M16.7

ICD-10 Finland

Other secondary coxarthrosis

5.5

90.0

176

326

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

89.9

1019

5245

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.8

89.8

1676

10120

T93.2

ICD-10 Finland

Sequelae of other fractures of lower limb

4.8

89.7

205

435

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.2

89.4

759

3495

UKC02

NOMESCO Finland

Cystoscopy

1.7

89.2

2067

13236

B01AA03

ATC

warfarin; systemic

1.6

89.2

2368

15694

R02

ICPC

Shortness of breath/dyspnoea

1.7

89.1

1822

11285

M09AX01

ATC

hyaluronic acid; parenteral

2.3

89.0

678

2982

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2517

11634

2.45

313.93

4.7

3.5

—

(3006315) Basophils [#/volume] in Blood

8136

58970

2.04

310.91

9.1

6.4

0.04

e9/l

0.18

7154

50402

(3001604) Monocytes [#/volume] in Blood

8112

58780

2.03

309.62

9.1

6.4

0.60

0.59

e9/l

2.11

7142

50224

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1072

1455

7.95

307.65

7.1

6.4

12.01

11.81

mg/l

0.57

1002

1350

(3024561) Albumin [Mass/volume] in Serum or Plasma

7822

52902

2.23

307.65

7.8

5.1

34.35

35.54

g/l

57.77

7486

49478

(3014111) Lactate [Moles/volume] in Serum or Plasma

2458

10847

2.57

307.65

11.1

7.5

1.28

1.34

mmol/l

2.00

2433

10630

(3007853) Bacteria identified in Skin by Aerobe culture

3691

13567

3.42

307.65

2.5

1.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1506

2189

7.66

307.65

2.4

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8614

61139

2.25

307.65

9.0

6.6

10.89

11.68

umol/l

7.82

8322

58229

(3013826) Glucose [Moles/volume] in Serum or Plasma

9323

68096

2.35

307.65

9.1

5.1

6.76

6.72

mmol/l

0.81

9080

64564

(3023368) Bacteria identified in Blood by Culture

6485

32775

2.98

307.65

6.5

4.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

3112

14022

2.61

307.65

11.1

7.5

12.67

12.34

kpa

2.65

3035

13483

(3044640) Blood type and Crossmatch panel - Blood

6396

37665

2.39

307.65

3.9

2.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7655

53070

2.10

307.65

11.6

6.6

1.20

1.21

mmol/l

48.67

7308

49034

(3013650) Neutrophils [#/volume] in Blood by Automated count

8875

65720

2.14

307.65

13.1

9.8

4.39

4.16

e9/l

13.05

7925

56806

(3000475) Leukocytes [#/volume] in Synovial fluid

1048

2845

3.92

307.65

2.0

1.5

19219.53

13778.65

e6/l

1.99

677

2004

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2766

11599

2.77

307.65

11.7

8.3

115.64

121.29

g/l

38.61

2715

11337

(3042936) Bacteria identified in Isolate by Culture

5227

16272

4.73

307.65

3.5

1.9

—

(3003396) Base excess in Arterial blood by calculation

3109

13892

2.63

307.65

11.0

7.5

1.07

0.92

mmol/l

1.27

2696

11427

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1156

3301

3.75

307.65

2.4

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

5002

28706

2.22

307.65

4.0

2.4

—

(3032080) INR in Blood by Coagulation assay

8264

54298

2.47

307.65

19.8

15.7

1.26

1.27

inr

1.01

7034

45391

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8713

53553

2.96

307.65

4.4

2.8

—

estimate

—

(3019977) pH of Arterial blood

3131

14013

2.63

307.65

11.1

7.5

7.41

7.42

1.55

1662

7606

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3111

14028

2.61

307.65

11.1

7.5

5.16

5.08

kpa

4.86

3032

13501

(3016502) Oxygen saturation in Arterial blood

2919

12482

2.73

307.65

11.2

7.8

96.05

95.50

5.18

2830

12053

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8237

59402

2.08

307.65

12.4

7.3

1.20

1.21

mmol/l

40.87

7268

51186

(3013115) Eosinophils [#/volume] in Blood

8290

60698

2.03

305.16

9.3

6.6

0.20

0.19

e9/l

0.67

7434

52744

(3031040) Bacteria [#/volume] in Urine by Automated count

9680

75155

2.17

302.33

7.1

4.8

2102.98

1988.34

e6/l

0.05

204

1038

(3014007) Fractional oxyhemoglobin in Arterial blood

1925

7983

2.66

300.61

13.3

9.4

94.54

93.88

6.17

1916

7954

(3000991) Gas panel - Venous blood

2305

10474

2.46

296.92

13.6

8.7

—

(3019198) Lymphocytes [#/volume] in Blood

8197

60114

2.01

295.92

9.1

6.4

1.81

1.91

e9/l

4.75

7367

52630

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1869

7709

2.67

294.66

13.4

9.6

0.63

0.64

0.15

1862

7659

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1908

7962

2.64

293.78

13.2

9.3

1.30

1.33

0.75

1899

7913

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3639

20104

2.13

293.13

2.4

1.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3617

20033

2.12

288.71

4.6

3.4

0.81

0.82

mmol/l

2.94

3470

18863

(3002582) Erythrocytes [#/volume] in Urine

5880

38719

1.96

288.60

4.8

3.5

79.51

78.49

e6/l

0.02

4773

29638

(3018418) pH of Serum or Plasma

5546

35823

1.97

287.89

6.5

4.3

7.40

0.03

4132

25608

(3000850) Epithelial cells [#/volume] in Urine

4438

26823

2.00

276.55

3.7

2.8

5.45

5.54

e6/l

0.18

4147

24419

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3337

18186

2.13

275.93

2.9

2.1

30.21

29.71

4.22

3249

17684

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1700

6901

2.69

275.56

13.0

9.8

15.37

16.03

18.04

1653

6666

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2754

13943

2.24

274.14

2.4

1.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

10631

87194

2.28

266.07

13.0

8.4

82.63

79.49

u/l

9.22

10337

82805

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2860

14922

2.18

262.84

2.3

1.8

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2974

15772

2.15

262.07

9.6

6.0

1.06

1.04

mmol/l

4.34

2847

14679

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4934

31416

1.93

260.01

2.9

2.4

2.97

2.82

mg/l

3.81

4444

27171

(3033658) Prothrombin time (PT) actual/Normal

4701

29542

1.93

256.99

6.7

4.2

88.48

88.84

0.44

4619

28897

(3018095) Leukocytes [#/volume] in Urine

6327

43851

1.87

254.76

5.8

4.1

95.41

100.90

e6/l

0.15

4897

31059

(3019069) Monocytes/Leukocytes in Blood

7422

54206

1.88

252.11

9.6

6.7

8.89

0.02

7115

50761

(3006504) Eosinophils/Leukocytes in Blood

7399

54069

1.87

249.93

9.5

6.6

2.84

0.03

7088

50611

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5562

37182

1.88

249.26

3.8

2.7

72.01

64.60

u/l

0.24

5244

34404

(3022096) Basophils/Leukocytes in Blood

7388

54068

1.86

247.23

9.6

6.7

0.66

0.68

1.79

7084

50578

(3002030) Lymphocytes/Leukocytes in Blood

7517

55422

1.86

244.42

9.5

6.6

25.77

27.49

34.74

7229

52453

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3416

19524

2.02

243.59

3.6

2.6

2.27

2.32

g/l

4.49

3203

17985

(3030467) Casts [#/volume] in Urine by Automated count

5121

33524

1.88

243.54

4.6

3.4

0.44

0.43

e6/l

0.15

4014

24677

(3022948) Iron [Moles/volume] in Serum or Plasma

3585

20875

2.00

242.28

3.6

2.6

11.56

12.88

umol/l

23.47

3382

19385

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1918

8753

2.40

240.71

2.0

1.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

2218

10849

2.26

236.53

11.4

7.4

10.51

10.06

mmol/l

1.96

2151

10367

(36304419) Bacteria [Presence] in Urine

4882

31824

1.86

232.45

4.5

3.3

0.79

122.29

estimate

0.69

137

(3018010) Neutrophils/Leukocytes in Blood

7347

54343

1.82

230.32

9.2

6.5

58.96

57.54

20.54

7152

51850

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1764

7961

2.41

226.02

11.4

8.0

24.91

24.77

mmol/l

0.89

1755

7908

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3163

18051

2.00

223.57

3.7

2.7

20.79

22.36

8.77

2986

16714

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1661

7367

2.44

220.88

9.9

6.8

24.77

24.47

mmol/l

2.15

1607

7052

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1641

7243

2.45

220.54

13.4

9.3

24.31

24.28

mmol/l

0.10

1626

7090

(3003329) Lymphocytes/Leukocytes in Synovial fluid

472

953

5.10

219.41

1.8

1.5

24.23

31.16

3.54

312

564

(3035350) Ketones [Presence] in Urine by Test strip

8006

61499

1.80

213.63

5.6

4.0

5.79

3.81

estimate

0.44

1935

13034

(3009261) Glucose [Presence] in Urine by Test strip

8043

61898

1.80

212.93

5.6

4.0

0.01

0.45

estimate

1.79

1857

12293

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1072

3933

2.88

208.45

3.9

3.2

0.34

0.35

iu/ml

0.83

584

2177

(3037467) Urinalysis macro (dipstick) panel - Urine

9576

77984

1.90

208.04

6.6

4.7

1.40

2.32

1.55

115

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4021

25397

1.85

206.07

2.2

1.8

1.39

1.26

mg/l

1.79

3330

19704

(3021601) Nitrite [Presence] in Urine by Test strip

7899

60808

1.78

205.14

5.6

4.0

0.00

estimate

3.28

1877

12710

(3012544) pH of Venous blood

2340

12355

2.09

202.61

6.2

3.9

7.37

7.38

2.45

1327

7122

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5480

38129

1.76

201.76

4.4

3.3

35.06

34.53

u/l

0.13

5232

35884

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2303

12173

2.09

198.41

6.2

3.9

5.86

5.82

kpa

1.22

2267

11881

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

10040

83520

1.93

197.80

6.4

4.5

15.58

12.43

mm/h

61.83

9611

78126

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2207

11518

2.11

196.52

2.6

2.3

0.20

0.21

g/l

1.03

2081

10741

(3006571) Granulocytes/Leukocytes in Synovial fluid

535

1321

4.18

193.50

1.9

1.5

63.88

58.15

2.40

353

819

(3026470) Cobalt [Mass/volume] in Blood

352

621

5.80

189.71

2.1

2.2

4.59

3.37

ug/l

1.86

327

576

(3002032) Base excess in Venous blood by calculation

2234

11854

2.07

189.65

6.4

3.9

1.72

1.80

mmol/l

0.41

2003

10391

(3044889) 12 lead EKG panel

9480

77828

1.84

189.42

5.4

4.2

7051.30

2670.51

0.25

162

(3025577) Chromium [Mass/volume] in Blood

347

605

5.87

189.34

2.2

2.83

2.32

ug/l

1.11

301

498

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7131

54117

1.72

186.66

4.2

3.1

145.62

129.37

ug/l

3.44

6689

50396

(3021589) Normoblasts [#/volume] in Blood

6756

50568

1.71

185.68

18.2

11.8

0.00

e9/l

0.44

5583

41114

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5239

36671

1.72

183.56

2.8

2.2

206.81

213.29

u/l

0.15

5009

34617

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3618

22825

1.82

181.66

5.3

4.0

378.48

451.81

ng/l

0.22

2978

18032

(40758558) Short blood count panel - Blood

4999

34700

1.72

179.38

8.6

6.5

—

(3015736) pH of Urine

6563

49153

1.69

176.31

4.8

3.6

6.28

6.23

3.37

3642

27128

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

911

3375

2.83

173.08

3.1

2.6

3.60

g/l

0.01

883

3223

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

867

3140

2.89

171.78

1.7

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1163

4889

2.52

171.62

2.5

1.9

2.14

2.15

ug/l

0.01

1063

4316

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

12008

108617

2.66

164.56

34.9

16.6

28.30

24.75

mg/l

29.61

11143

90221

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5077

36077

1.67

162.24

3.8

3.2

1982.45

1411.10

ng/l

7.70

4545

31207

(3015377) Calcium [Moles/volume] in Serum or Plasma

5567

40617

1.65

159.81

4.2

3.5

2.35

2.36

mmol/l

6.75

5170

36833

(3021960) Folate [Moles/volume] in Serum or Plasma

4864

34292

1.67

159.44

1.9

1.7

20.42

20.13

nmol/l

0.49

4336

29103

(3027945) Reticulocytes/Erythrocytes in Blood

2433

14197

1.88

153.34

3.3

2.6

1.87

1.78

4.21

2249

12599

(3026782) Osmolality of Urine

3512

22941

1.73

151.24

3.8

3.0

509.48

532.07

mosm/kgh2o

8.44

3176

20126

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6772

52529

1.61

147.19

3.1

2.5

77.09

77.70

nmol/l

1.03

6276

47504

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1022

4337

2.47

147.02

2.9

2.2

488.84

609.67

ug/l

0.55

983

4107

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5906

44368

1.61

146.26

5.1

3.9

53.97

75.97

ng/l

0.67

4446

31476

(3024354) Oxygen [Partial pressure] in Venous blood

1870

10159

1.98

145.29

4.9

3.3

4.69

4.51

kpa

3.21

1837

9893

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1432

7087

2.15

143.21

7.0

4.0

24.13

24.21

mmol/l

0.45

1427

7012

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3248

21073

1.72

141.74

4.1

3.1

0.98

1.29

e6/l

1.35

1850

11281

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1723

9283

1.99

136.46

4.5

2.7

63.81

65.53

ml/min/173m2

0.96

826

3952

(3019550) Sodium [Moles/volume] in Serum or Plasma

12068

110736

2.52

136.35

38.8

19.7

139.21

139.66

mmol/l

69.09

11971

108612

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2372

14213

1.82

135.44

4.8

4.5

239.41

244.11

u/l

0.94

2273

13448

(3034891) Synovial lining cells/cells in Synovial fluid

268

502

5.43

135.33

1.7

1.5

4.61

3.37

0.58

103

(3023103) Potassium [Moles/volume] in Serum or Plasma

12077

110966

2.51

134.05

39.0

19.9

3.99

3.97

mmol/l

9.67

11973

108658

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1303

6377

2.16

133.63

4.4

3.0

1.33

1.23

2.78

1298

6347

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5973

45758

1.57

130.78

5.6

4.0

0.04

0.45

estimate

2.80

1611

10444

(3023520) Reticulocytes [#/volume] in Blood

1944

11058

1.89

130.57

3.2

2.6

71.39

69.17

e9/l

1.68

1406

8150

(3004119) Hemoglobin [Mass/volume] in Venous blood

1457

7504

2.06

130.48

4.7

3.4

123.01

129.13

g/l

19.56

1423

7290

(3000494) Fungus identified in Specimen by Culture

2323

14007

1.80

129.25

1.9

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1279

6306

2.14

128.47

4.5

2.9

0.63

0.62

0.56

1274

6284

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2262

13647

1.80

125.19

3.7

2.7

7.53

8.78

umol/l

2.15

1982

11950

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

10286

90009

1.72

125.07

38.3

20.4

14.04

13.66

118.42

10218

88850

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1921

11052

1.87

123.99

2.5

2.3

368.62

379.46

nmol/l

1.41

1816

10212

(3026493) Urate [Moles/volume] in Serum or Plasma

4288

30832

1.59

120.86

3.5

2.8

350.36

343.77

umol/l

3.53

3794

27096

(40760892) CBC W Ordered Manual Differential panel - Blood

3669

25469

1.62

119.61

6.3

4.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3998

28333

1.60

119.55

5.2

3.9

0.04

0.37

1.24

305

(3018405) Lactate [Moles/volume] in Arterial blood

887

3868

2.39

119.45

5.9

3.9

1.36

1.40

mmol/l

0.35

869

3798

(3029937) Albumin [Presence] in Urine by Test strip

4629

33974

1.57

118.83

6.0

4.2

0.00

estimate

4.05

1754

11707

(3020891) Body temperature

1148

5589

2.16

118.71

6.8

4.5

36.90

36.91

°c

0.40

1138

5535

(3047181) Lactate [Moles/volume] in Blood

822

3476

2.46

118.47

8.0

5.8

1.32

mmol/l

0.00

733

3082

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6582

52267

1.53

117.65

2.5

2.2

94.54

95.93

pmol/l

1.64

3756

27827

(3003694) ABO and Rh group [Type] in Blood

4409

32074

1.57

117.27

1.5

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1790

10346

1.85

113.00

2.8

2.6

65.53

66.24

g/l

3.47

1676

9432

(3017143) Hepatitis C virus Ab [Presence] in Serum

2084

12691

1.77

110.32

2.0

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2892

19263

1.65

109.76

4.3

3.2

3.06

2.59

e6/l

1.22

1485

9422

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1138

5716

2.09

108.07

1.9

1.7

1.61

1.54

g/l

1.28

994

4913

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1373

7380

1.96

107.91

2.1

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2889

19332

1.64

107.29

2.2

1.9

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

754

3209

2.43

106.92

3.5

2.5

196.80

196.46

0.03

719

3055

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

792

3460

2.37

105.92

3.0

2.4

91.06

92.40

0.88

777

3335

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1884

11316

1.78

104.03

3.4

2.5

62.81

42.67

u/l

0.58

1594

9596

(3019150) Specific gravity of Urine by Refractometry

3741

26903

1.55

101.26

5.7

4.2

1.02

1.19

kg/l

1.05

2609

17929

(3005719) IgG [Mass/volume] in Serum or Plasma

1552

8955

1.83

97.50

3.2

2.9

10.31

10.53

g/l

0.99

1433

8287

(3037522) Nuclear Ab [Titer] in Serum

2452

16088

1.65

97.17

1.4

532.75

503.40

titre

0.30

499

3438

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1621

9518

1.80

96.05

3.9

3.0

219.53

199.95

ng/l

1.16

1502

8686

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1056

5394

2.04

95.37

7.3

5.0

1.73

1.59

4.08

1002

5120

(3007930) Methemoglobin/Hemoglobin.total in Blood

987

4947

2.08

93.79

7.7

5.2

0.87

0.17

935

4687

(3036489) Thrombin time

880

4231

2.16

93.22

2.8

2.1

21.26

21.10

0.18

795

3748

(3024928) Oxygen saturation in Venous blood

694

3028

2.37

92.86

5.0

3.2

63.40

61.19

1.74

683

2930

(3043409) Potassium [Moles/volume] in Arterial blood

723

3224

2.32

91.99

6.3

4.2

3.90

3.89

mmol/l

0.41

717

3193

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

792

3686

2.22

90.95

1.4

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

689

3031

2.35

90.43

1.9

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3317

23702

1.54

90.41

3.2

3.1

2.46

2.45

mmol/l

2.57

2990

21235

(3002256) Pathology report gross observation

2360

15583

1.63

90.40

1.4

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2483

16675

1.61

88.51

2.0

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1638

9874

1.76

88.19

3.2

2.5

0.49

0.45

e6/l

0.31

1551

9469

(3039000) Anion gap in Blood by calculation

579

2388

2.49

87.64

9.3

6.9

11.11

11.32

mmol/l

0.78

521

2149

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1552

9227

1.78

87.63

5.9

3.8

114.15

90.29

ng/l

9.68

1397

7915

(3018572) Chloride [Moles/volume] in Blood

579

2389

2.49

87.56

9.3

6.9

104.94

105.10

mmol/l

0.34

521

2151

(3019230) Fractional oxyhemoglobin in Venous blood

599

2565

2.40

83.48

4.9

2.9

63.35

61.51

1.17

599

2557

(3019309) Folate [Moles/volume] in Red Blood Cells

2908

20529

1.54

82.52

1.9

1.8

1271.31

1156.17

nmol/l

9.01

2375

15460

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3378

24623

1.50

82.42

1.9

1.7

25465843.13

28957869.83

pmol/l

0.14

2847

20392

(3028026) IgM [Mass/volume] in Serum or Plasma

1240

7016

1.85

82.20

2.2

2.0

1.27

1.33

g/l

0.49

1144

6442

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

686

3136

2.25

82.13

2.0

1.6

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

12177

115024

2.16

80.25

40.3

21.8

82.31

78.26

umol/l

14.11

12112

113663

(3028626) Oxygen [Partial pressure] in Capillary blood

663

3022

2.26

79.91

4.6

3.3

8.14

8.16

kpa

0.14

650

2950

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

733

3481

2.17

79.84

1.6

1.7

0.24

0.23

g/l

1.93

698

3309

(3010144) Erythrocytes [#/volume] in Synovial fluid

330

1064

3.16

79.65

1.6

1.4

187376.44

138438.58

e6/l

0.45

226

705

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1621

10016

1.71

79.26

2.7

2.4

7.10

7.38

ug/l

0.20

1464

8727

(3041096) Erythrocytes [Presence] in Urine by Automated

4218

32466

1.45

76.77

4.8

3.4

0.18

0.32

estimate

0.37

1602

10086

(3007164) IgA [Mass/volume] in Serum or Plasma

3118

22636

1.50

76.57

1.7

1.5

2.51

2.44

g/l

1.13

2007

13876

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7746

66428

1.42

76.43

3.4

2.9

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

739

3588

2.12

75.99

1.6

1.7

1.22

1.19

g/l

1.35

708

3420

(1616796) Gas panel - Central venous blood

603

2702

2.29

75.64

4.6

3.8

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

999

5414

1.92

75.47

4.7

3.5

25.17

25.20

mmol/l

0.10

967

5243

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

562

2462

2.34

74.29

9.0

5.6

1199.77

1793.02

iu/ml

0.30

104

353

(3010421) pH of Blood

757

3758

2.08

73.35

4.6

3.7

7.41

0.31

747

3711

(3009445) Proteinase 3 Ab [Units/volume] in Serum

943

5067

1.93

73.02

1.5

1.6

12.68

16.75

iu/ml

0.44

136

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9622

86212

1.46

72.05

5.1

4.5

14.90

14.82

pmol/l

2.22

8975

79095

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8493

74456

1.42

70.98

4.5

3.3

57.24

48.67

u/l

10.68

8084

69743

(3009508) Creatinine [Moles/volume] in Urine

5066

40739

1.40

70.37

4.0

3.5

7.02

7.48

mmol/l

12.01

4371

34338

(3014051) Protein [Presence] in Urine by Test strip

4195

32690

1.42

69.62

3.9

3.0

0.09

0.07

0.15

791

(40761536) Microorganisms panel - Urine sediment

1478

9205

1.68

69.57

5.7

4.1

—

(3017181) Myelocytes/Leukocytes in Blood

1670

10735

1.64

69.51

5.2

4.4

0.85

0.94

0.98

616

3300

(3023183) Ammonium ion [Moles/volume] in Plasma

563

2543

2.27

69.23

2.5

2.8

32.60

33.89

umol/l

0.66

507

2285

(3027315) Oxygen [Partial pressure] in Blood

545

2466

2.26

66.71

5.0

4.0

8.48

8.62

kpa

1.03

535

2411

(3021901) Oxygen saturation in Capillary blood

553

2521

2.25

66.48

3.9

3.0

89.86

89.78

0.09

540

2456

(3002179) Metamyelocytes/Leukocytes in Blood

1591

10221

1.64

66.15

5.0

4.3

0.67

0.71

0.30

572

3145

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1048

6016

1.81

65.66

4.9

4.1

50.39

47.04

4.25

1034

5931

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12036

114121

1.89

64.58

19.1

12.4

26.06

26.04

u/l

0.02

11855

110776

(3012501) Base excess in Blood by calculation

537

2450

2.24

64.42

5.0

4.0

2.55

2.51

mmol/l

0.11

410

1639

(3013290) Carbon dioxide [Partial pressure] in Blood

537

2452

2.24

64.29

5.0

4.0

5.05

4.98

kpa

1.50

527

2398

(3015235) Bicarbonate [Moles/volume] in Capillary blood

801

4253

1.94

64.05

4.0

2.9

24.86

24.74

mmol/l

0.34

784

4182

(40767503) Oxygen content in Capillary blood by calculation

543

2505

2.22

63.39

3.3

2.7

15.90

16.34

2.48

530

2458

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

790

4192

1.94

63.26

2.8

2.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10975

101712

1.55

63.11

6.3

5.5

1.87

1.93

mu/l

3.44

10338

94098

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1364

8544

1.67

62.41

1.6

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

449

1925

2.38

62.27

4.0

2.7

634.60

1340.86

u/ml

0.66

112

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1130

6758

1.74

61.33

5.0

3.5

2.18

1.82

mmol/l

2.90

850

4988

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

570

2726

2.14

60.76

1.7

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

372

1480

2.56

60.64

1.8

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

372

1480

2.56

60.64

1.8

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

372

1480

2.56

60.64

1.8

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

372

1480

2.56

60.64

1.8

1.4

—

(3021440) Promyelocytes/Leukocytes in Blood

1573

10279

1.60

60.63

5.3

4.5

0.08

0.11

1.20

525

2855

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1287

8001

1.68

60.52

5.2

3.7

5.18

5.14

kpa

0.91

1239

7627

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3390

25947

1.42

60.34

1.4

1.3

1.70

1.74

u/ml

0.06

935

6971

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2831

20981

1.45

60.16

1.4

1.3

33.03

34.27

iu/ml

0.14

882

6320

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

795

4304

1.90

59.87

1.3

—

(40768804) Tissue Pathology biopsy report

5526

45873

1.36

59.81

2.5

2.2

—

(3025941) Bacteria identified in Stool by Culture

1036

6107

1.76

59.08

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

592

2908

2.09

58.82

2.8

2.3

125.06

129.13

g/l

3.58

484

2223

(3009343) pH of Capillary blood

1249

7768

1.67

58.54

5.1

3.7

7.41

7.42

1.78

1096

6420

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1471

9556

1.61

57.93

5.7

3.9

1.22

1.23

mmol/l

1.83

1309

8235

(3025159) Blasts/Leukocytes in Blood

1562

10382

1.57

55.68

5.5

4.7

0.55

0.33

0.40

485

2725

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

11016

102744

1.51

55.44

7.7

6.5

40.03

39.38

mmol/mol

11.00

10520

95991

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

11159

104409

1.53

54.80

30.0

16.3

80.33

80.00

ml/min/173m2

0.78

10643

96816

(3007461) Platelets [#/volume] in Blood

12249

117405

1.96

54.67

48.8

25.4

256.17

249.89

e9/l

18.62

12119

115036

(3012516) Albumin [Mass/volume] in Urine

4687

38315

1.35

54.39

3.9

3.5

65.94

48.34

mg/l

4.58

3183

24430

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2625

19497

1.44

54.30

1.4

1.3

12.11

11.66

u/ml

0.12

1013

7514

(3026250) Tacrolimus [Mass/volume] in Blood

177

491

3.64

54.26

50.0

38.9

7.43

7.27

ug/l

0.31

164

443

(3026361) Erythrocytes [#/volume] in Blood

12250

117444

1.96

54.23

48.7

25.3

4.32

4.47

e12/l

189.53

12086

114685

(3035941) MCH [Entitic mass]

12249

117432

1.96

54.22

48.6

25.2

30.25

30.34

7.05

12178

116188

(3024731) MCV [Entitic mean volume] in Red Blood Cells

12249

117436

1.96

54.15

48.6

25.3

91.38

91.19

4.29

12180

116191

(3000963) Hemoglobin [Mass/volume] in Blood

12250

117460

1.96

53.96

49.2

25.5

129.10

134.81

g/l

293.66

12184

116250

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

153

6.12

53.92

11.8

11.3

5.15

5.32

mmol/l

0.28

153

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

12248

117439

1.95

53.89

50.2

25.8

38.90

40.72

36.62

12178

116144

(3010813) Leukocytes [#/volume] in Blood

12249

117461

1.95

53.73

48.8

25.4

7.12

6.76

e9/l

39.35

12089

114675

(3020682) Albumin/Creatinine [Ratio] in Urine

4754

39016

1.35

53.48

4.6

4.2

13.25

8.66

mg/mmol

6.22

3095

24268

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

767

4272

1.85

52.72

3.2

3.3

41.22

47.28

mg/l

0.61

632

3616

(3034860) Kappa light chains.free [Mass/volume] in Serum

765

4274

1.84

52.05

3.2

3.4

56.22

67.36

mg/l

0.39

633

3613

(3015171) Extractable nuclear Ab [Units/volume] in Serum

792

4482

1.82

51.68

1.2

1.3

1.14

1.02

u/ml

0.09

379

(3011648) Oxygen content in Venous blood

312

1239

2.56

51.07

2.9

2.4

10.72

10.69

0.04

312

1234

(3019420) Tryptase [Mass/volume] in Serum or Plasma

198

614

3.26

51.07

1.5

1.6

7.39

8.43

ug/l

0.50

179

557

(3003181) Sodium [Moles/volume] in Urine

473

2255

2.14

50.78

1.6

1.4

59.50

61.96

mmol/l

0.62

386

1802

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1801

12618

1.50

49.94

4.5

4.3

19.07

27.65

ug/l

0.56

1461

10348

(3042733) HLA Ab [Presence] in Serum

138

341

4.08

49.86

6.4

4.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

477

2299

2.12

49.78

1.6

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

422

1940

2.22

49.64

1.3

1.4

9.82

13.06

u/ml

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

192

601

3.23

48.78

2.1

2.3

100.46

96.82

0.63

184

565

(4035726) Immunohistochemistry procedure

1518

10308

1.54

48.73

1.5

1.4

—

(40768797) Stomach Pathology biopsy report

2217

16254

1.44

48.52

1.3

—

(3028271) Lactate [Moles/volume] in Capillary blood

405

1848

2.23

48.52

2.1

1.9

1.67

1.71

mmol/l

0.37

392

1804

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

691

3822

1.85

48.50

3.1

3.2

2.38

4.96

ratio

1.42

386

2200

(3022806) Fractional oxyhemoglobin in Capillary blood

329

1380

2.42

47.92

2.0

1.8

89.21

89.61

0.50

324

1362

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

855

5075

1.73

47.28

2.3

2.4

3.77

3.69

g/l

0.69

807

4624

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

856

5084

1.73

47.23

2.3

2.4

4.21

4.20

g/l

0.08

810

4634

(3000570) Elastase.pancreatic [Mass/mass] in Stool

659

3623

1.86

47.13

1.5

1.4

262.22

270.80

ug/g

0.47

406

2148

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

856

5091

1.73

46.99

2.3

2.4

7.55

7.40

g/l

1.84

809

4636

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

760

4382

1.78

46.49

2.3

10.07

10.16

g/l

0.21

708

3876

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

354

1555

2.31

46.44

1.8

1.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

812

4793

1.74

45.77

1.8

7.80

7.15

iu/ml

0.20

191

1111

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

811

4786

1.74

45.75

2.3

2.4

3.05

2.90

g/l

4.18

765

4333

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

140

373

3.78

45.58

1.3

1.2

0.32

0.30

g/l

1.98

114

297

(3052851) Hemolysis interference index of Serum or Plasma

607

3289

1.89

45.41

4.1

3.2

1.99

2.05

index

0.07

319

1685

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

346

1520

2.31

45.39

1.7

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

433

2085

2.11

45.29

2.1

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

11105

104620

1.46

44.35

5.7

5.3

6.05

5.96

mmol/l

9.36

10364

96088

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

133

350

3.83

44.09

1.3

1.2

114.12

111.23

0.50

121

308

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

504

2591

1.98

44.08

1.6

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1803

12939

1.46

43.79

2.2

1.8

1.60

1.47

8.05

1560

11268

(3037756) Immunofixation for Serum or Plasma

497

2557

1.98

43.37

1.6

1.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

623

3456

1.84

43.26

1.4

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

462

2320

2.03

43.16

1.7

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

142

397

3.61

43.11

3.5

2.6

0.62

mmol/l

0.52

142

397

(3035947) Staphylolysin Ab [Units/volume] in Serum

170

534

3.21

42.99

1.2

1.1

4.13

3.84

iu/ml

0.19

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

523

2747

1.94

42.97

1.4

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

234

881

2.69

42.71

2.4

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

643

3616

1.82

42.71

1.6

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

654

3706

1.81

42.36

2.4

0.00

0.03

g/l

3.17

601

3332

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

460

2329

2.01

42.00

1.9

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

633

3566

1.82

41.79

2.4

0.00

g/l

0.50

570

3117

(3028707) Methadone [Presence] in Urine by Screen method

364

1691

2.19

41.74

3.3

2.9

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

119

304

3.94

41.15

1.7

1.3

65.35

54.84

2.14

106

250

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

596

3326

1.83

40.58

2.4

0.00

g/l

-0.00

567

3109

(3005322) IgE [Units/volume] in Serum or Plasma

1104

7263

1.57

40.47

1.5

1.3

280.11

238.52

u/ml

0.19

1026

6726

(3017732) Neutrophils [#/volume] in Blood

1983

14693

1.41

40.11

3.7

3.2

4.59

4.53

e9/l

0.14

1766

12624

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

433

2183

2.02

40.01

1.4

1.3

257.35

267.85

u/ml

0.32

281

1377

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

270

1125

2.43

39.95

1.9

1.4

—

(3023419) Bacteria identified in Sputum by Culture

335

1538

2.21

39.57

2.6

2.4

—

(3048689) Calprotectin [Mass/mass] in Stool

1977

14677

1.41

39.49

2.5

2.4

140.05

135.40

ug/g

0.24

1616

11661

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

451

2320

1.98

39.37

1.8

1.4

17.82

19.64

u/ml

—

(3036670) Protein [Mass/volume] in Synovial fluid

125

349

3.61

38.08

1.5

1.2

42.44

39.65

g/l

1.15

175

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

614

3553

1.76

36.99

1.4

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

510

2790

1.86

36.99

1.7

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

412

2102

1.99

36.83

1.9

1.4

158.06

150.18

au/ml

0.67

127

622

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

472

2530

1.90

36.47

1.6

1.4

75.55

32.19

e6/l

0.61

338

1855

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

158

525

3.03

36.39

2.6

1.9

115.62

135.11

umol/l

0.44

271

(44816559) Phosphatidylethanol [Mass/volume] in Blood

756

4655

1.66

36.29

2.0

1.7

0.32

0.31

mg/l

0.12

376

2174

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

721

4405

1.67

35.65

2.6

2.4

0.75

0.85

g/l

0.31

638

3781

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

474

2566

1.88

35.53

1.7

1.4

1381.14

2737.05

e6/l

0.40

359

2016

(3024980) IgG subclass 4 [Mass/volume] in Serum

388

1967

2.00

35.32

1.5

1.6

0.74

0.80

g/l

0.35

297

1519

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

372

1859

2.03

35.25

1.8

1.4

—

(3024471) HLA-A [Type]

115

325

3.56

34.44

1.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

148

491

3.04

34.21

2.1

1.9

171.40

153.62

1.30

141

464

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1066

7226

1.52

33.89

3.4

3.5

4.40

4.47

pmol/l

1.28

966

6451

(3017569) Oxygen content in Arterial blood

180

669

2.71

33.78

3.1

2.2

15.04

15.99

3.69

180

669

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

512

2896

1.80

33.32

1.5

1.3

617.89

542.83

mg/l

1.08

488

2769

(3024263) Appearance of Synovial fluid

158

555

2.87

33.00

1.8

1.7

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

122

5.35

32.93

1.1

1.0

0.60

0.39

u/ml

0.15

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

136

440

3.11

32.84

2.2

2.1

73.57

62.36

ug/l

0.70

131

429

(3022145) Colonoscopy Study observation

1796

13501

1.38

32.76

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

620

3721

1.70

32.76

1.6

0.22

9.23

iu/ml

1.11

118

732

(3024932) HLA-DR beta [Type]

111

319

3.50

32.43

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

864

5648

1.57

32.36

1.1

2.16

10.69

u/ml

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

275

1268

2.19

32.20

1.3

1.2

68.18

64.03

u/l

0.32

247

1094

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

111

322

3.47

31.98

1.2

114.11

103.74

1.61

104

293

(3020191) Ethanol [Moles/volume] in Serum or Plasma

221

932

2.40

31.92

1.8

1.4

1.43

1.19

promille

1.41

182

719

(3004809) Band form neutrophils/Leukocytes in Blood

385

2020

1.93

31.75

3.8

3.7

1.53

1.55

0.04

354

1804

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

700

4375

1.63

31.63

3.6

3.5

221.24

1879.77

u/ml

1.86

607

3776

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

565

3345

1.72

31.38

1.7

1.4

26.52

14.96

iu/ml

0.51

(3044242) Glucose [Moles/volume] in Arterial blood

174

665

2.64

30.95

3.0

1.9

8.25

8.04

mmol/l

0.24

174

665

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

100

277

3.63

30.90

1.5

1.2

36.01

39.53

0.39

182

(40768446) Kidney Pathology biopsy report

131

430

3.07

30.89

2.3

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

428

2348

1.85

30.78

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

428

2348

1.85

30.78

1.4

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

592

3569

1.69

30.75

4.5

3.5

1.81

1.57

mg/l

6.76

549

3249

(3002619) Bacteria identified in Specimen by Culture

102

288

3.56

30.64

1.4

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

197

806

2.47

30.43

1.4

1.2

76.02

82.44

0.44

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

211

892

2.39

30.34

1.4

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

288

1387

2.10

30.19

8.4

10.5

8.09

7.29

mmol/l

0.89

248

1155

(3014765) Yersinia sp identified in Stool by Organism specific culture

520

3043

1.74

30.11

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

11353

108638

1.39

30.08

6.3

5.9

2.54

2.68

mmol/l

54.07

10679

101067

(3026389) Candida sp identified in Specimen by Organism specific culture

333

1695

1.99

30.01

1.6

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

516

3021

1.74

29.83

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

139

483

2.90

29.66

30.4

28.8

126.06

113.43

ug/l

0.83

104

397

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

330

1686

1.98

29.43

1.3

1.2

4.80

3.25

u/ml

0.47

128

607

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

105

311

3.40

29.33

1.2

93.10

85.06

1.17

156

(42529406) Shigella sp [Presence] in Stool by Culture

518

3054

1.73

29.20

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

260

1221

2.15

29.11

1.5

1.4

6.62

6.75

g/l

0.18

192

866

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

183

741

2.49

28.93

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

221

975

2.29

28.83

2.0

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

221

975

2.29

28.83

2.0

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

221

975

2.29

28.83

2.0

1.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

323

1650

1.98

28.83

1.3

1.2

3.73

4.11

u/ml

0.21

146

766

(3024139) IgG subclass 3 [Mass/volume] in Serum

259

1221

2.14

28.72

1.5

1.4

0.40

0.42

g/l

0.54

191

864

(3028192) IgG subclass 2 [Mass/volume] in Serum

259

1222

2.14

28.66

1.5

1.4

2.76

2.93

g/l

0.83

193

869

(1001926) Buprenorphine [Presence] in Urine by Screen method

517

3075

1.71

28.23

3.0

2.2

—

(3000012) Reticulocyte production index

345

1818

1.92

28.12

2.5

2.1

0.91

0.89

0.21

253

1224

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

104

317

3.30

27.78

1.2

1.1

89.33

85.90

0.48

152

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

114

368

3.12

27.70

2.2

1.9

178.06

184.31

0.24

108

350

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

858

5792

1.52

27.68

3.7

61.64

69.25

u/ml

0.18

836

5587

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

11181

106988

1.35

27.40

5.5

5.2

4.44

4.60

mmol/l

52.59

10566

99887

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

445

2560

1.76

27.36

1.4

1.3

3.70

3.78

mmol/l

0.81

422

2423

(4034850) Laboratory test

561

3439

1.66

27.34

14.5

10.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

236

1099

2.17

27.02

3.2

3.0

—

(4062490) Immunoglobulin typing, IgG

250

1198

2.11

26.61

1.5

1.4

—

(3009015) Lactate [Moles/volume] in Synovial fluid

123

4.81

26.58

1.4

1.2

7.30

6.21

mmol/l

0.55

(3045414) Leukocytes [Presence] in Urine

1524

11519

1.37

26.46

2.5

2.1

0.01

0.02

estimate

0.89

300

2285

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

213

3.77

26.25

1.3

1.2

89.17

73.25

1.40

(3042631) Mycobacterium sp identified in Specimen

307

1605

1.94

25.65

2.6

2.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10666

101567

1.30

25.62

4.6

4.3

1.35

1.28

mmol/l

16.31

9925

93263

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

276

1397

2.00

25.33

1.3

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

391

2222

1.78

25.09

1.3

1.2

267.65

295.00

titre

0.11

170

(3017315) Amylase [Enzymatic activity/volume] in Urine

151

599

2.54

24.99

1.3

1.2

293.67

302.74

u/l

0.04

144

550

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

11101

106368

1.32

24.87

5.4

5.1

1.41

1.46

mmol/l

30.38

10418

98699

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

207

948

2.20

24.75

1.8

1.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

213

3.68

24.70

1.2

79.27

71.02

0.54

(40757494) Bilirubin.total [Moles/volume] in Blood

147

582

2.54

24.44

2.1

2.3

30.27

29.81

umol/l

0.01

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

375

2.95

24.37

3.6

3.2

4.88

4.94

kpa

0.21

110

375

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

376

2.94

24.26

3.6

3.2

10.30

10.34

kpa

0.04

110

376

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

9588

90317

1.24

24.12

43.2

21.3

330.52

332.14

g/l

54.77

9555

89799

(3011288) Drugs identified in Urine by Screen method Nominal

452

2708

1.69

24.05

4.0

3.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

188

843

2.25

23.69

2.0

2.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

620

4046

1.56

23.32

1.6

1.7

—

(3013512) EKG study

4572

40132

1.22

23.27

4.3

3.7

0.79

0.02

102

(4268621) Lupus anticoagulant assay

239

1188

2.03

23.11

2.5

2.3

—

(3034770) Mitochondria Ab [Titer] in Serum

518

3256

1.62

22.86

1.2

993.57

853.88

titre

0.13

(3004451) EKG impression Narrative

161

687

2.36

22.79

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

202

959

2.12

22.11

1.8

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

519

3291

1.60

22.10

1.2

113.02

132.56

titre

0.23

328

(3049717) Cytology report of Urine Cyto stain

668

4487

1.52

22.02

2.9

2.7

—

(3008295) Osmolality of Serum or Plasma

257

1335

1.94

21.95

1.6

1.4

277.81

278.24

mosm/kgh2o

0.10

205

992

(3016879) Cocaine [Presence] in Urine

567

3678

1.57

21.91

2.9

2.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

546

3512

1.58

21.88

1.8

1.7

357.55

296.55

mu/l

2.46

499

3186

(4195642) Thrombophilia screening test

284

1533

1.87

21.60

1.2

—

(4198724) Urine methamphetamine measurement

116

435

2.68

21.57

2.1

3.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

720

4950

1.48

21.19

2.0

1.9

38.73

39.34

u/l

0.35

654

4365

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.96

21.06

1.2

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

201

3.50

20.63

1.5

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

420

2572

1.65

20.60

1.3

52.64

45.35

u/ml

0.32

246

(3023323) Follitropin [Units/volume] in Serum or Plasma

720

4979

1.47

20.57

1.5

1.4

26.89

28.29

iu/l

0.54

598

4251

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5212

46713

1.19

20.39

2.1

1.9

1.41

1.35

mmol/l

3.82

4364

39122

(3022621) pH of Urine by Test strip

1216

9228

1.35

20.31

3.3

2.7

6.04

6.07

0.65

876

6228

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

110

4.47

20.25

1.2

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

281

1546

1.84

20.15

1.2

1.1

119.40

116.43

0.75

268

1386

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

235

1222

1.94

20.05

2.1

1.7

—

(3011985) Renin [Units/volume] in Plasma

306

1737

1.78

19.79

1.4

1.5

51.96

63.87

mu/l

0.70

273

1557

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

508

3292

1.57

19.73

1.3

7.55

6.49

u/ml

0.21

475

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

174

821

2.13

19.41

1.3

1.12

1.98

u/ml

0.94

118

459

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

506

3289

1.56

19.39

1.3

5.55

4.00

u/ml

0.26

306

(40768443) Skin Pathology biopsy report

772

5473

1.44

19.35

1.3

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

535

3527

1.54

19.25

1.3

39.28

36.82

u/ml

0.05

195

(3011412) CD3 cells [#/volume] in Blood

215

1101

1.97

19.20

2.6

2.4

1292.67

1178.00

e6/l

0.85

182

973

(3000764) Benzodiazepines [Presence] in Urine

585

3941

1.51

19.02

2.9

2.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

159

730

2.19

19.01

1.3

1.2

27.30

25.59

u/l

0.16

135

598

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

219

1133

1.95

18.99

2.1

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

533

3530

1.53

18.78

2.9

2.3

5935.50

5484.78

u/l

0.11

184

1381

(36660697) Celiac disease serology panel - Serum

1190

9110

1.34

18.69

1.2

—

(3028300) Cannabinoids [Presence] in Urine

587

3972

1.50

18.69

2.9

2.1

—

(3027008) Opiates [Presence] in Urine

586

3964

1.50

18.68

2.9

2.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

273

1525

1.81

18.66

1.6

1.4

1964.70

2972.74

e6/l

0.80

183

1058

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

131

560

2.35

18.56

1.7

1.5

2279593.78

1226194.57

iu/ml

—

(3010838) Calcium [Moles/time] in 24 hour Urine

345

2065

1.69

18.50

1.9

4.67

4.94

mmol/24h

0.74

303

1834

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

225

1187

1.91

18.43

1.2

1.1

97.25

96.62

0.12

214

1108

(3003434) Protein [Mass/volume] in Pleural fluid

302

1745

1.75

18.40

1.5

1.4

31.62

32.41

g/l

0.48

272

1579

(3009466) Valproate [Moles/volume] in Serum or Plasma

281

1591

1.78

18.37

5.6

5.1

352.43

358.04

umol/l

0.26

240

1373

(3042111) Morphology [Interpretation] in Bone marrow Narrative

340

2032

1.69

18.34

1.8

1.6

—

(1175426) CD3 cells/Lymphocytes in Blood

182

893

2.05

18.34

2.2

2.1

73.38

72.71

0.20

169

858

(3009214) Lutropin [Units/volume] in Serum or Plasma

471

3057

1.56

18.19

1.4

11.02

10.41

u/l

0.40

369

2452

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

284

1620

1.77

18.10

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

261

1452

1.81

18.10

1.3

51.83

62.10

u/ml

0.23

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

480

3136

1.55

18.00

2.0

11.59

11.79

mg/l

0.20

448

2921

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

160

753

2.14

18.00

1.3

1.2

87.05

91.63

u/l

0.25

137

631

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

283

1618

1.77

17.90

1.2

1.3

384.54

374.70

pmol/l

0.03

237

1359

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

175

855

2.06

17.85

2.1

2.0

14.70

15.20

0.24

168

836

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

224

1193

1.89

17.84

2.4

25.56

28.95

iu/ml

0.15

132

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

350

2.70

17.81

1.2

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

369

2271

1.64

17.79

2.3

1.9

—

(3020618) Glucose [Moles/volume] in Synovial fluid

7.23

17.78

1.1

4.39

5.07

mmol/l

0.39

(3014148) Varicella zoster virus Ab [Titer] in Serum

260

1453

1.81

17.77

1.2

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

245

1345

1.84

17.74

1.5

1.4

86497.39

57167.22

e6/l

0.57

140

747

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

435

2789

1.58

17.72

1.2

1.3

1.70

3.88

u/ml

1.03

179

(3027944) Amphetamines [Presence] in Urine

573

3911

1.49

17.49

2.9

2.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

620

4313

1.46

17.19

2.3

1.8

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1163

8979

1.32

17.18

1.5

—

(3017354) Segmented neutrophils/Leukocytes in Blood

236

1304

1.82

16.77

3.7

3.6

58.89

57.73

0.36

209

1124

(3008757) Leukocyte morphology finding [Identifier] in Blood

218

1177

1.87

16.68

4.2

3.9

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

214

1155

1.87

16.40

3.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

116

498

2.34

16.34

3.5

5.3

1575.00

962.16

mg/l

0.15

356

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1088

13959

0.76

16.29

5.2

5.0

32.65

32.62

0.03

789

9269

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

255

1460

1.76

16.10

1.3

0.19

0.20

nmol/l

0.36

186

1163

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

659

4701

1.42

15.96

2.6

2.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

386

2474

1.58

15.79

3.5

3.2

0.82

nmol/l

0.00

316

1979

(3045788) Cell count panel - Pleural fluid

223

1237

1.82

15.67

1.5

1.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

282

1674

1.70

15.66

1.4

1.3

0.59

3.22

nmol/l

1.20

273

1621

(3016650) Hepatitis A virus Ab [Presence] in Serum

312

1906

1.65

15.54

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

287

1717

1.69

15.49

1.4

1.3

0.17

0.22

nmol/l

0.58

109

(3023511) Choriogonadotropin [Units/volume] in Urine

279

1659

1.70

15.41

1.7

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.72

15.36

5.0

4.5

—

(3016038) Potassium [Moles/volume] in Urine

162

819

1.99

15.12

1.4

1.2

29.53

35.17

mmol/l

2.81

144

713

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

839

6292

1.36

15.05

2.3

2.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

703

5124

1.39

15.05

1.3

1.4

—

(4024509) Urine culture

747

5500

1.38

15.05

2.3

2.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

170

876

1.95

15.02

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

216

1205

1.81

14.93

1.4

1.3

6.77

6.31

mmol/l

1.35

203

1116

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

175

913

1.93

14.91

1.2

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

338

2129

1.60

14.91

1.4

1.3

62.91

32.01

u/l

1.31

307

1838

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

110

481

2.30

14.89

2.3

1.7

27.30

29.47

umol/l

1.60

105

453

(3020961) Endomysium IgA Ab [Titer] in Serum

715

5237

1.39

14.87

1.2

1.1

402.14

182.49

titre

0.56

147

(3045142) Bone marrow Pathology biopsy report

235

1346

1.76

14.86

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

430

2866

1.52

14.77

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

176

925

1.92

14.68

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

174

912

1.92

14.64

1.2

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

179

948

1.90

14.59

1.2

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

126

588

2.15

14.58

2.4

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

126

588

2.15

14.58

2.4

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

126

588

2.15

14.58

2.4

1.8

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

136

654

2.09

14.57

2.6

2.7

39.65

39.10

0.10

357

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

126

589

2.15

14.52

2.3

1.8

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

124

576

2.16

14.52

12.3

13.5

0.61

0.62

mmol/l

0.27

115

526

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

170

888

1.93

14.45

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

165

854

1.94

14.41

1.2

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

114

514

2.23

14.37

2.3

2.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1252

9991

1.28

14.36

2.3

2.1

—

(40762365) Oxygen content in Arterial blood by calculation

192

3.08

14.35

4.2

2.8

14.48

14.83

ml/dl

0.41

178

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

150

755

2.00

14.20

2.7

2.4

611.85

518.18

e6/l

1.27

110

608

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

136

664

2.06

14.01

1.2

1.1

33.01

25.34

u/l

0.72

127

582

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

804

6073

1.35

13.76

2.4

—

(3012441) Differential panel - Pleural fluid

225

1302

1.74

13.76

1.5

—

(3017704) Immunofixation for Urine

131

637

2.07

13.65

1.4

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

703

5211

1.37

13.59

2.2

2.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

305

2.57

13.52

2.4

1.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

395

2.36

13.50

1.5

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

216

1243

1.75

13.48

2.0

2.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

205

2.94

13.44

1.9

1.5

89.05

116.68

ug/l

1.54

173

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1344

10903

1.26

13.43

2.4

2.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

272

1671

1.64

13.32

1.2

7.56

8.24

u/ml

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

964

7511

1.31

13.27

1.2

103.16

140.69

u/ml

3.03

364

2781

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

417

2.31

13.26

1.8

2.1

30.19

29.39

0.18

398

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

135

672

2.02

13.22

1.2

1.1

91.54

84.57

u/l

0.35

127

589

(3051611) Lipemic interference index of Serum or Plasma

204

1163

1.77

13.16

4.6

3.4

15.01

13.44

index

0.84

131

646

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

306

1943

1.59

13.10

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

423

2884

1.48

13.06

1.2

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

254

1545

1.66

12.95

2.5

1.35

1.22

g/24h

0.36

164

912

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

237

2.75

12.94

1.3

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

363

2404

1.52

12.90

1.5

1.4

126.40

176.30

pmol/l

1.44

353

2339

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

206

1185

1.75

12.90

1.6

1.3

1.54

1.50

nmol/l

0.22

189

1061

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

188

1055

1.79

12.81

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

139

708

1.97

12.78

1.8

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

350

2.41

12.75

1.2

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

437

2.25

12.74

1.2

0.06

0.33

g/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

291

2.55

12.70

1.4

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

149

779

1.92

12.70

2.9

2.6

210.65

228.41

e6/l

0.48

124

664

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

212

2.84

12.67

1.3

98.91

90.84

mg/l

0.04

152

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

158

843

1.89

12.66

2.2

17.66

18.16

nmol/l

0.26

149

794

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

122

596

2.06

12.60

3.9

3.8

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

142

738

1.93

12.33

1.8

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

233

2.71

12.23

2.9

2.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

203

1182

1.73

12.20

1.4

1.3

406.26

364.13

u/l

0.21

189

1122

(3038071) Oxygen [Partial pressure] in Mixed venous blood

262

2.60

12.19

13.6

7.7

6.04

5.39

kpa

0.79

262

(3022313) Gas panel - Capillary blood

718

5434

1.34

12.14

5.8

3.8

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

196

2.87

12.05

1.9

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

124

620

2.01

12.04

1.3

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

331

2.40

11.88

1.2

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

114

556

2.06

11.85

1.8

1.5

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

113

550

2.06

11.82

1.6

1.3

54.17

64.04

0.58

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

148

797

1.87

11.57

1.8

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

141

748

1.89

11.54

3.0

2.6

0.72

0.67

e9/l

0.34

128

711

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

128

3.29

11.45

1.2

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

104

498

2.10

11.37

3.7

3.5

1.05

1.32

1.09

104

498

(3023410) Appearance of Cerebral spinal fluid

192

1126

1.72

11.29

1.6

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

255

2.56

11.26

1.1

1.10

5.92

u/ml

0.75

132

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

371

2.27

11.23

1.6

1.2

36.24

23.93

0.76

(3035880) pH of Pleural fluid

125

645

1.95

11.13

1.3

7.40

7.41

0.19

434

(3021162) Amylase [Enzymatic activity/volume] in Specimen

217

2.68

11.05

4.7

2.7

2703.10

1746.55

u/l

0.30

199

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

114

572

2.00

11.00

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

146

799

1.84

10.88

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

248

1570

1.59

10.84

1.6

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

883

11066

0.78

10.81

1.9

2.0

3.50

3.46

ratio

0.37

658

8539

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

455

2.12

10.81

1.1

1.2

—

(3000330) Specific gravity of Urine by Test strip

769

5976

1.31

10.81

4.0

3.5

1.02

ratio

0.21

699

5378

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

148

816

1.82

10.77

1.5

1.4

—

(3037121) Protein [Mass/volume] in Urine

547

4055

1.36

10.62

3.7

3.2

772.50

479.31

mg/l

0.56

304

1810

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

135

727

1.87

10.60

1.7

1.5

6.69

6.59

u/l

0.03

108

574

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.23

10.53

1.3

1.2

0.45

0.75

iu/ml

0.55

(3020717) Zinc [Moles/volume] in Serum or Plasma

126

666

1.90

10.48

2.1

1.5

18.61

22.26

umol/l

0.84

118

616

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

158

900

1.76

10.33

2.0

1.69

1.63

u/field

0.06

484

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.16

10.33

3.5

3.6

—

(21494434) Karyotype in Bone marrow

176

1034

1.71

10.32

1.2

—

(3010503) CD19 cells [#/volume] in Blood

131

705

1.87

10.32

3.0

2.5

128.91

371.33

e6/l

1.24

124

680

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

159

909

1.76

10.27

1.2

134.78

184.15

titre

0.38

159

(21494755) Public health laboratory ask at order entry panel

716

9152

0.77

10.26

1.3

1.4

—

(3012565) Volume of 24 hour Urine

114

590

1.94

10.11

2.3

2.2

1770.10

1943.20

1.01

105

519

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

280

1853

1.52

10.08

3.7

3.9

31.46

37.96

u/ml

0.60

273

1795

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

124

662

1.88

10.02

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

114

3.25

9.95

1.8

1.85

1.51

mg/l

0.66

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

140

779

1.81

9.93

1.2

—

(40768793) Breast Pathology biopsy report

383

2706

1.43

9.91

1.4

1.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

250

1622

1.55

9.86

2.8

2.7

918.25

1029.53

u/ml

0.04

244

1604

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

138

769

1.80

9.75

1.2

—

(3006245) CD3-CD19+ cells/cells in Blood

430

2.08

9.58

2.2

11.70

10.05

0.34

403

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

238

1539

1.56

9.55

1.7

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

111

582

1.92

9.50

1.4

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

111

582

1.92

9.50

1.4

1.6

—

(3016228) CD19 cells/cells in Blood

472

2.02

9.49

2.4

2.0

5.92

8.39

1.82

458

(3027231) Wheat IgE Ab [Units/volume] in Serum

177

2.72

9.46

1.0

1.1

0.22

2.60

u/ml

0.93

149

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

109

570

1.92

9.41

1.9

1.8

1.95

2.86

u/field

0.88

397

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

433

3155

1.39

9.40

2.0

3.02

8.18

iu/l

1.03

176

1272

(3006922) Hepatitis E virus Ab [Presence] in Serum

156

911

1.72

9.40

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

381

2.13

9.36

2.0

2.11

1.75

ratio

0.96

367

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

129

3.03

9.35

2.3

3.5

40.81

39.90

umol/l

0.09

110

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

368

2611

1.42

9.33

2.4

119.89

99.86

ug/min

0.39

227

1549

(3035611) Eosinophils/Leukocytes in Synovial fluid

3.81

9.20

2.2

1.5

0.46

0.69

0.38

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

156

918

1.71

9.15

1.3

1.6

29.90

24.44

u/ml

0.64

177

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

154

905

1.71

9.08

1.6

1.3

2.30

2.13

mmol/l

0.63

145

849

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3962

36337

1.13

9.00

5.7

2.32

3.21

ug/l

3.49

3585

32881

(3000093) Morphology [Interpretation] in Blood Narrative

189

1175

1.62

8.99

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.64

8.97

1.7

1.6

3.53

1.84

mg/l

0.54

(3008898) HLA-B27 [Presence]

489

3663

1.35

8.93

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

218

2.48

8.91

2.5

2.0

16.00

16.62

umol/l

0.15

218

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

106

560

1.90

8.90

1.1

—

(3001729) Color of Synovial fluid

3.45

8.89

2.1

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

557

4263

1.32

8.79

6.1

3.8

24.75

24.86

mmol/l

0.33

519

3891

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

480

1.97

8.73

2.3

2.4

52.40

52.70

umol/l

0.02

423

(3042517) Benzodiazepines panel - Urine

103

3.21

8.73

3.2

2.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

384

2781

1.39

8.68

1.1

4.97

7.73

eliau/ml

0.66

329

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

104

551

1.89

8.67

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

123

688

1.80

8.64

1.8

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

646

8181

0.78

8.61

1.7

3.34

3.47

mmol/l

1.81

436

5634

(40768806) Pleura Pathology biopsy report

204

1306

1.57

8.60

1.5

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

497

1.94

8.58

1.2

1.1

219.70

192.16

iu/ml

0.28

490

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

227

1491

1.53

8.54

1.6

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

119

662

1.81

8.52

1.5

1.11

1.25

nmol/l

0.88

497

(3025468) Yersinia sp identified in Specimen by Organism specific culture

226

1485

1.53

8.49

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

227

1494

1.53

8.46

1.6

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

357

2.11

8.45

1.1

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

233

1546

1.52

8.37

1.7

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

385

2810

1.38

8.32

1.2

4.40

3.91

0.41

346

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

134

778

1.73

8.30

1.1

—

0.62

—

(37208534) Antinuclear antibody arbitrary concentration in serum

356

2.08

8.13

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

558

4320

1.30

8.13

1.6

15.32

17.94

u/ml

0.48

988

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

435

3259

1.35

7.98

1.3

209.42

226.70

miu/ml

0.38

142

1453

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.52

7.95

1.7

1.6

0.39

1.40

mg/l

1.13

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.52

7.95

1.7

1.6

2.75

3.39

mg/l

0.20

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.52

7.95

1.7

1.6

0.69

0.91

mg/l

0.35

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.52

7.95

1.7

1.6

4.14

1.96

mg/l

0.66

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.52

7.95

1.7

1.6

1.12

2.46

mg/l

1.02

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.52

7.95

1.7

1.6

1.04

2.65

mg/l

1.49

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.52

7.95

1.7

1.6

2.67

3.64

mg/l

0.35

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.52

7.95

1.7

1.6

2.24

4.10

mg/l

1.12

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.52

7.95

1.7

1.6

1.00

1.39

mg/l

0.39

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

224

1492

1.51

7.93

1.5

1.3

28.31

27.79

u/l

0.08

197

1225

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.34

7.91

1.2

1.1

1.87

1.62

iu/ml

0.30

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

115

2.96

7.89

1.2

121.15

107.30

ug/l

0.17

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

185

1183

1.57

7.88

1.1

—

14.74

—

(3002079) Sodium [Moles/time] in 24 hour Urine

527

1.87

7.85

1.2

1.3

134.23

165.05

mmol/24h

4.08

527

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

121

698

1.74

7.70

1.7

1.5

5.17

6.08

u/l

1.48

102

593

(40768795) Lymph node Pathology biopsy report

186

1200

1.56

7.64

1.3

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

110

619

1.78

7.63

1.2

1.09

1.06

ratio

0.90

497

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

948

7876

1.22

7.56

2.4

23.17

21.57

au/ml

0.20

825

(21494814) CD8 cells/Lymphocytes in Specimen

477

1.89

7.56

2.5

2.0

31.10

31.44

0.07

477

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

169

2.55

7.55

1.3

1.2

781.90

51.97

u/l

0.50

120

(3034274) Bile acid [Moles/volume] in Serum --fasting

188

1221

1.55

7.50

2.4

2.2

11.45

8.07

umol/l

0.47

138

897

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

164

2.57

7.48

1.0

1.1

0.64

6.49

u/ml

1.04

106

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.07

7.41

1.1

0.06

0.03

u/ml

0.78

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

314

2264

1.40

7.35

4.0

1.8

0.94

0.84

nmol/l

1.60

264

1926

(3000060) B lymphocytes [#/volume] in Blood

311

2.10

7.29

2.1

2.2

2.00

0.36

e9/l

0.64

150

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

3.48

7.25

10.4

11.7

341.87

312.12

e6/l

0.05

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

247

2.23

7.22

1.5

1.3

1.17

mmol/l

0.09

247

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

133

803

1.66

7.20

1.5

1.4

13.77

12.71

umol/l

0.75

127

749

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

436

1.91

7.18

2.8

2.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

877

7270

1.22

7.16

1.3

48.47

53.62

au/ml

0.28

481

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

268

1891

1.43

7.11

1.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

288

2.12

7.09

1.9

1.6

0.35

0.40

ug/l

0.65

195

(4027681) Cerebrospinal fluid IgG ratio and IgG index

111

641

1.74

7.08

1.3

1.2

0.50

0.61

ratio

2.76

377

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

193

1278

1.52

7.08

1.8

1280.00

1538.82

titre

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1108

9405

1.19

7.06

2.7

2.3

11.85

13.03

nmol/l

5.12

989

8455

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

432

1.90

7.04

2.8

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

432

1.90

7.04

2.8

2.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1123

9554

1.19

6.98

1.9

1.8

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.85

6.96

1.1

1.0

0.03

0.08

u/ml

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

232

1601

1.46

6.95

1.1

1.55

1.52

g/l

0.53

222

1443

(40761539) Cells [Type] in Urine sediment by Light microscopy

271

2.15

6.93

1.5

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

108

624

1.74

6.89

3.7

3.1

25.96

25.54

mu/l

0.04

102

586

(3002621) Streptococcal DNAse B [Units/volume] in Serum

104

2.89

6.72

1.2

1.0

295.33

372.58

u/ml

—

(3044927) Protein electrophoresis panel - Urine

180

1192

1.52

6.63

1.1

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

438

3379

1.31

6.62

2.1

1.8

42.07

41.96

nmol/l

0.03

424

3279

(3036071) Salmonella sp Ab [Titer] in Serum

330

2.01

6.62

1.1

—

(40757373) Influenza virus identified in Isolate

194

2.32

6.53

1.5

1.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

146

927

1.58

6.50

1.4

1.3

11.60

14.79

u/l

0.95

131

849

(3042010) Triglyceride [Moles/volume] in Pleural fluid

195

2.31

6.46

1.3

1.2

2.10

1.32

mmol/l

0.22

134

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

176

1171

1.51

6.36

1.6

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

136

2.58

6.34

1.1

1.2

0.18

0.43

u/ml

0.42

(3014271) Vancomycin [Susceptibility]

558

1.74

6.32

3.1

2.9

—

(3016750) Collection duration of Urine

104

612

1.71

6.25

2.1

2.3

494.70

496.67

min

0.06

462

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

103

2.82

6.24

1.0

0.01

4.26

u/ml

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

422

1.85

6.23

1.4

62.28

65.47

0.32

355

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

251

1796

1.41

6.22

1.1

28.55

16.03

au/ml

0.75

408

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

136

859

1.59

6.21

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

116

708

1.64

6.09

1.8

1.6

90.42

83.12

umol/l

0.80

116

708

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

207

2.23

6.07

5.8

7.2

9.78

10.43

1.02

207

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

341

1.94

6.07

2.0

8.30

9.28

mg/l

0.88

287

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

103

613

1.69

5.96

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

158

1044

1.52

5.93

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

147

958

1.54

5.88

1.3

8.62

8.79

mmol/l

0.21

138

912

(44813793) Dust mix specific IgE antibody measurement

124

777

1.60

5.88

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

148

968

1.54

5.83

1.4

1.2

102.18

108.54

pmol/l

0.95

148

968

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

177

1203

1.48

5.81

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

199

1388

1.44

5.72

3.2

3.5

5.50

14.43

nmol/l

0.92

189

1354

(3020393) Adenovirus Ag [Presence] in Stool

114

2.64

5.71

1.4

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

340

2591

1.32

5.68

3.4

3.5

62.12

797.38

u/ml

5.32

304

2351

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

175

2.29

5.66

2.4

3.0

106.47

28.38

mg/l

1.50

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.76

5.61

1.0

0.72

0.79

u/ml

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

2.76

5.61

1.6

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

250

3391

0.73

5.59

1.1

0.61

0.62

ratio

0.08

459

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

113

702

1.62

5.57

1.1

3.37

9.48

nmol/l

1.35

133

(3001186) Copper [Moles/volume] in Serum or Plasma

296

1.96

5.56

1.7

1.3

17.10

16.57

umol/l

0.32

258

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

141

924

1.53

5.53

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

3.23

5.43

1.4

1.1

1.08

1.05

u/field

0.11

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

129

2.48

5.43

1.5

1.3

71.94

73.09

0.07

106

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

124

793

1.57

5.43

2.4

1.9

155.79

109.00

ng/l

1.36

124

793

(40762814) Titanium [Mass/volume] in Blood

192

2.19

5.38

2.4

6.54

3.19

ug/l

1.11

(3013637) Mi-2 Ab [Presence] in Serum

344

1.86

5.28

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

344

1.86

5.28

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

344

1.86

5.28

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

344

1.86

5.28

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

446

1.75

5.26

1.8

315.44

58583.98

u/ml

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

100

612

1.64

5.26

1.1

1.26

1.11

u/l

0.48

248

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

129

839

1.54

5.26

1.1

369.68

265.82

mg/l

0.81

107

742

(3001893) Eosinophils/Leukocytes in Pleural fluid

354

1.84

5.16

1.4

2.31

2.65

0.14

304

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

354

1.84

5.16

2.6

3.6

7.21

8.59

mg/l

0.86

283

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

103

2.62

5.13

1.0

0.02

0.31

u/ml

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

209

1502

1.40

5.13

1.1

3.59

2.76

0.44

218

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

391

1.79

5.12

2.7

2.9

29.96

27.82

umol/l

0.70

293

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

152

2.31

5.08

1.9

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

238

2.02

5.02

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

147

2.32

4.99

1.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

156

1069

1.46

4.98

1.3

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

148

1005

1.48

4.95

2.1

1.8

4.15

4.08

mg/l

0.06

143

961

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

154

2.28

4.94

1.9

1.2

40.43

54.51

1.14

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

563

1.64

4.87

1.6

3.75

5.66

nmol/l

0.70

458

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

124

2.42

4.86

1.3

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

120

783

1.54

4.85

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

131

872

1.51

4.83

1.1

1.2

57.97

40.61

mg/l

0.47

740

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

122

800

1.53

4.83

1.4

1.3

168.18

66.43

titre

0.41

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

113

2.48

4.77

4.3

3.4

1.60

1.12

mg/l

0.56

(3008116) Ketones [Moles/volume] in Urine by Test strip

271

1.92

4.75

1.6

1.5

0.12

0.33

mmol/l

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

220

1618

1.37

4.73

1.5

0.32

0.38

nmol/l

0.81

168

1211

(3041918) Cholesterol [Moles/volume] in Pleural fluid

244

1.97

4.71

1.3

1.2

1.44

1.61

mmol/l

0.57

155

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

615

1.60

4.71

1.1

1597.24

1527.42

miu/ml

0.29

615

(3028433) Virus identified in Specimen by Culture

359

1.79

4.66

1.2

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

169

1192

1.42

4.65

1.7

375.28

359.06

mu/l

0.23

145

943

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

2.84

4.64

1.0

0.40

2.38

u/ml

0.72

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

404

1.74

4.62

2.7

2.6

146.44

145.33

nmol/l

0.03

358

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

253

1.94

4.61

1.8

2.5

607.78

146.86

ug/l

0.50

253

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

331

2592

1.28

4.60

2.3

1.9

189.97

201.28

pmol/l

1.22

315

2442

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

318

1.83

4.55

1.2

16.87

12.41

pmol/l

0.59

121

(3045424) Erythrocytes [Presence] in Urine

694

5894

1.19

4.48

2.5

2.1

0.01

0.16

estimate

0.53

234

1775

(3033923) Metanephrine [Moles/time] in 24 hour Urine

221

1.99

4.48

1.1

0.65

0.67

umol/24h

0.06

102

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1500

13478

1.13

4.47

12.1

7.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

203

1494

1.36

4.38

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.09

4.35

3.0

2.7

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

123

828

1.49

4.35

1.4

1.3

703.64

495.25

titre

0.18

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

465

1.66

4.34

1.0

1.1

105.67

335.96

ng/l

1.69

123

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

164

2.14

4.29

1.5

1.6

4.98

236964.29

nmol/l

0.91

138

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

156

1104

1.42

4.26

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

158

2.15

4.25

1.1

—

(4281824) Cell count and differential, peritoneal fluid

178

1289

1.39

4.25

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

366

2933

1.26

4.23

3.9

3.2

1.60

1.59

mmol/l

0.04

353

2853

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

569

1.59

4.23

1.7

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

569

1.59

4.23

1.7

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

159

2.14

4.19

1.0

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

320

1.78

4.18

2.1

2.7

179.56

141.22

au/ml

0.21

(3047007) Chlamydophila sp Ab [Presence] in Serum

207

1544

1.35

4.12

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

4.34

4.12

10.1

8.7

—

(3014891) Appearance of Pleural fluid

154

2.15

4.10

1.5

—

(3004775) Volume in Urine collected for unspecified duration

124

848

1.47

4.08

2.2

2.3

749.40

642.34

1.87

580

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3110

29140

1.09

4.05

4.7

4.6

22.33

22.09

0.34

1511

14714

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

402

1.67

3.91

1.4

1.5

14.35

15.91

pmol/l

1.57

328

(3046861) Legionella sp Ag [Presence] in Urine

2.72

3.91

1.3

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

464

1.62

3.89

1.8

2.1

1403.54

3583.96

e6/l

0.52

312

(3026051) Granulocytes/Leukocytes in Pleural fluid

269

1.82

3.88

1.5

1.4

27.14

23.16

0.39

227

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

171

1252

1.37

3.86

1.2

58.00

35.34

u/ml

0.37

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.97

3.84

1.7

1.5

594.76

461.97

nmol/l

0.44

(3016031) Almond IgE Ab [Units/volume] in Serum

2.68

3.81

1.0

0.38

0.76

u/ml

—

(4211845) Urine protein measurement

562

1.55

3.78

3.4

3.3

—

(3009871) Measles virus Ab [Titer] in Serum

437

1.63

3.77

1.5

1.6

4515.56

3096.67

titre

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

897

7892

1.15

3.73

1.2

1.3

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

3.83

3.68

1.6

1.4

166.86

145.19

ug/l

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.79

3.68

1.2

1422.67

4053.98

ng/l

—

(3034426) Prothrombin time (PT)

356

1.69

3.67

1.3

1.2

29.47

28.32

0.62

356

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

574

1.54

3.67

2.6

2.3

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

2.53

3.62

1.3

1.2

0.74

1.07

ml/s/173m2

0.97

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

313

1.73

3.60

1.7

1.6

10.73

9.28

ug/l

1.26

313

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

276

2193

1.26

3.51

1.2

1.1

1.44

1.91

u/ml

0.55

170

1167

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

10.00

3.49

5.0

5.5

0.67

12.33

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

333

1.68

3.42

1.3

1.5

14.40

13.14

g/l

0.42

253

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

592

1.51

3.42

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

434

1.59

3.40

1.0

1.1

102.77

94.69

1.34

334

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.52

3.39

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

2.44

3.37

1.1

—

21.43

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

106

734

1.45

3.34

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

185

1405

1.32

3.34

1.1

2.57

3.67

eliau/ml

0.63

633

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

414

1.60

3.30

1.5

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.92

3.29

43.9

9.8

100.07

105.94

g/l

0.96

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

248

1.78

3.26

1.2

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

377

1.62

3.24

1.4

1.3

3.23

3.48

mmol/l

0.20

343

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

552

1.51

3.22

1.4

1.3

4.15

4.74

umol/l

0.68

487

(3018851) Theophylline [Moles/volume] in Serum or Plasma

103

2.24

3.21

2.2

1.6

59.17

45.34

umol/l

0.72

103

(3020650) Glucose [Presence] in Urine

386

1.61

3.20

1.7

0.00

0.04

estimate

1.60

386

(3007463) Buprenorphine [Presence] in Urine

3.25

3.13

6.5

6.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

397

1.59

3.11

1.5

2.0

23277.88

16877.03

e6/l

0.21

206

(3020911) Cortisol [Moles/time] in 24 hour Urine

405

1.58

3.10

1.4

92.00

290.00

nmol/24h

1.61

405

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

655

5727

1.15

3.03

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

174

1.90

3.03

1.3

1.2

143.84

609.46

ng/l

0.49

115

(3028679) Herpes simplex virus Ab [Presence] in Serum

587

1.47

2.97

1.2

1.1

—

(3018291) Platelet Ab [Presence] in Serum

4.71

2.91

1.0

—

(3006462) Nitrate [Presence] in Urine

516

1.50

2.91

3.5

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

606

1.46

2.91

2.4

2.3

201.16

200.82

u/l

0.02

597

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.32

2.90

1.0

—

(44786800) Granulocytes/Leukocytes in Body fluid

135

2.00

2.89

1.2

1.3

20.74

25.31

0.26

104

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

134

994

1.35

2.89

1.4

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

517

1.49

2.89

1.2

1.1

—

0.12

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.43

2.87

1.3

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

351

1.60

2.85

1.6

1.3

113.68

128.87

nmol/l

0.29

253

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

328

1.62

2.84

4.3

3.0

1.55

1.97

ratio

1.43

297

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.16

2.84

2.4

3.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

237

1905

1.25

2.81

1.1

4.12

4.81

u/ml

0.34

142

1007

(1761868) Lipid panel - Serum or Plasma

3959

41350

0.94

2.81

3.5

3.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

109

788

1.39

2.77

1.1

7.68

9.36

iu/ml

0.34

202

(3020874) Milk IgE Ab [Units/volume] in Serum

609

1.43

2.67

1.1

2.07

1.69

u/ml

0.11

183

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

147

1.91

2.64

1.8

1.5

0.21

0.26

nmol/l

0.35

101

(3044007) Cell count panel - Peritoneal fluid

399

1.53

2.62

1.9

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.93

2.61

2.8

4.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

546

1.45

2.60

1.1

1.0

0.18

1.12

u/ml

0.89

128

(40765096) Chromosome analysis panel by Banding

361

1.55

2.57

1.2

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

2.19

2.56

1.0

1.36

0.89

u/ml

0.13

(3035320) C reactive protein [Mass/volume] in Body fluid

124

929

1.34

2.55

3.8

2.7

28.73

28.79

mg/l

0.01

679

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

2.35

2.55

1.1

1.0

6.95

6.69

u/ml

0.02

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.86

2.54

1.6

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

178

1405

1.27

2.50

1.1

—

(36303858) Crystals [Presence] in Urine

4.38

2.47

1.4

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

158

1.84

2.47

1.3

—

(4212803) Bone marrow aspirate examination

102

2.06

2.46

1.2

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

294

1.60

2.46

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.13

2.43

1.1

1.2

—

(3016330) Potassium [Moles/time] in 24 hour Urine

152

1.84

2.41

1.2

1.3

—

85.80

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

5.00

2.40

1.0

1.1

0.01

0.41

u/ml

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

204

1.72

2.40

2.1

1.9

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

273

1.61

2.39

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

3.64

2.36

1.3

1.5

1.73

2.04

mmol/24h

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.64

2.36

3.8

4.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

133

1021

1.31

2.34

5.5

5.3

50.77

90.24

u/ml

0.91

329

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

245

1.63

2.30

2.2

2.3

7.62

7.70

mmol/l

0.04

151

(3044009) aPTT.lupus sensitive (LA screen)

2.12

2.28

1.1

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

148

1.83

2.27

1.9

1.10

mmol/l

0.00

103

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

406

1.48

2.25

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

433

4964

0.87

2.24

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

108

811

1.33

2.23

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

149

1.81

2.23

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.09

2.22

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

194

1.70

2.21

2.2

2.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

295

1.56

2.20

1.3

1.4

26.61

25.95

g/l

0.10

230

(3047189) Immunofixation for 24 hour Urine

575

1.39

2.18

2.1

1.8

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.50

2.18

1.9

3.9

13.80

9.65

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

214

1757

1.22

2.17

1.1

29.95

6554.13

iu/ml

0.59

383

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.00

2.14

3.8

5.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.16

2.14

1.5

345.56

308.16

umol/24h

0.25

(44806071) Cardiolipin IgM antibody measurement

152

1.78

2.11

1.0

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

259

1.58

2.11

1.1

1.2

—

366.15

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

222

1840

1.21

2.07

1.1

0.46

0.94

u/ml

2.59

110

809

(3006969) Lambda light chains [Mass/volume] in Urine

2.70

2.06

1.1

0.01

0.09

g/l

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

548

1.39

2.06

2.0

2.1

86.06

150.08

ug/min

0.66

142

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

117

1.88

2.05

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.50

2.05

3.3

3.1

—

(3050794) Legionella sp Ab [Presence] in Serum

110

1.91

2.05

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

126

981

1.29

2.04

3.3

3.0

95.45

50.47

mg/l

0.47

100

724

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

230

1.61

2.04

1.8

2.15

2.06

ug/l

0.08

124

(3042951) Complement C1q Ab [Units/volume] in Serum

2.40

2.02

2.4

1.1

27.25

17.57

u/ml

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

491

1.41

2.02

1.1

47.43

17.16

u/ml

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

147

1.77

2.01

1.0

—

(3022229) Phosphate [Moles/volume] in Urine

2.22

2.00

1.5

1.9

19.52

16.67

mmol/l

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.63

2.00

1.1

0.00

0.66

u/ml

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

104

1.92

1.99

1.0

0.53

0.12

u/ml

0.35

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.96

1.99

2.3

2.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.28

1.97

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.33

1.96

2.4

1.4

2.24

2.20

g/l

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

105

1.91

1.95

1.0

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

4.55

1.94

1.0

0.04

0.06

u/ml

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.92

1.89

2.6

2.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

227

1.59

1.89

1.3

—

(3038026) Centromere Ab [Units/volume] in Serum

117

913

1.28

1.89

1.2

34.84

45.97

u/ml

—

(3003129) Base excess in Capillary blood by calculation

177

1450

1.22

1.88

2.6

2.3

0.88

0.47

mmol/l

0.81

161

1393

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

121

1.82

1.87

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.65

1.86

3.1

1.9

4.01

4.49

mmol/l

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.86

1.86

1.3

—

mmol/l

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

252

1.55

1.86

1.1

1.2

354.08

299.76

pmol/l

0.18

183

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

122

1.80

1.83

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

690

1.32

1.83

7.4

6.8

17.28

117.70

ug/l

1.28

439

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

278

1.51

1.80

1.2

1.3

—

(3007733) Chloride [Moles/volume] in Urine

2.76

1.79

1.0

1.2

99.00

84.96

mmol/l

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

223

1.57

1.78

2.9

3.2

157.76

124.75

ng/l

0.35

104

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

131

1.76

1.77

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

288

1.49

1.76

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

132

1058

1.25

1.74

1.2

72.00

69.46

u/ml

—

(40768441) Liver Pathology biopsy report

111

873

1.27

1.72

1.6

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

194

1.60

1.70

1.6

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

299

1.47

1.69

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

181

1509

1.20

1.65

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

284

2460

1.16

1.65

4.2

3.4

7.56

7.61

mmol/l

0.12

271

2396

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

487

1.36

1.62

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/cells in Blood

135

1.70

1.61

12.6

8.9

0.30

0.20

1.20

135

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

713

1.29

1.61

1.1

21.13

19.05

u/ml

0.11

284

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.38

1.61

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.87

1.60

1.6

1.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

601

1.32

1.59

1.1

0.87

2.30

u/ml

1.16

141

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

106

1.79

1.58

1.1

1.82

0.58

u/ml

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

136

1.69

1.58

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

3.00

1.58

1.2

1.0

242.33

254.54

u/ml

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1304

12267

1.07

1.55

1.7

1.6

—

6.25

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

176

1.59

1.54

1.5

1.4

14.27

10.60

0.25

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

3.33

1.52

1.0

5920.00

2410.67

titre

—

(3032057) Clostridioides difficile [Presence] in Stool

241

1.50

1.51

2.9

1.8

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

1.83

1.51

1.0

1.1

0.36

2.39

u/ml

0.71

(3020491) Glucose [Moles/volume] in Blood

103

819

1.26

1.50

2.1

1.9

7.43

6.65

mmol/l

1.53

588

(37021550) Renin [Units/volume] in Plasma --upright

234

1.50

1.48

1.3

127.17

103.38

mu/l

0.17

172

(3010726) Horse dander IgE Ab [Units/volume] in Serum

206

1758

1.17

1.48

1.1

1.83

1.34

u/ml

0.31

133

879

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.73

1.43

3.8

2.7

1.87

1.98

mu/l

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

533

1.32

1.43

1.3

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

180

1.56

1.42

1.5

1.2

71.39

63.68

ug/l

0.95

180

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

133

1.66

1.42

1.4

1.1

21.60

20.28

u/l

0.17

(40760410) HLA-B [Type] by High resolution

2.17

1.39

1.0

—

(40760409) HLA-A [Type] by High resolution

2.17

1.39

1.0

—

(46236302) HLA-C [Type] by High resolution typing

2.17

1.39

1.0

—

(3034614) HLA Ag [Interpretation]

2.94

1.36

1.0

1.4

—

(3036180) Methadone [Presence] in Urine

2.94

1.36

1.8

2.5

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

2.50

1.30

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

269

2372

1.14

1.28

5.8

3.5

26.55

28.33

mg/l

0.40

222

1638

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

177

1.53

1.28

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

153

1.57

1.28

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

531

0.71

1.27

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

354

1.36

1.24

1.4

1.2

34.81

369.48

ug/l

2.04

186

(3017400) Magnesium [Moles/volume] in Urine

2.40

1.24

1.0

3.06

2.55

mmol/l

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

123

1.63

1.23

2.9

2.5

0.45

0.57

u/field

0.34

123

(40763590) HLA-DQ beta [Type]

2.00

1.23

1.0

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

163

1.53

1.22

1.5

1.6

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

2.63

1.21

1.6

1.4

—

0.73

u/field

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

229

1.44

1.21

11.3

5.1

41.27

61.88

u/l

1.21

222

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

108

898

1.20

1.11

1.0

1.1

299.99

288.29

mg/l

0.85

101

816

(3032352) Blasts [#/volume] in Cerebral spinal fluid

119

1.60

1.11

2.4

2.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.82

1.08

1.0

0.01

0.20

u/ml

1.05

(3025130) Human papilloma virus identified in Specimen

178

1548

1.15

1.08

2.0

1.8

—

(3019174) dRVVT (LA screen)

1.69

1.07

1.1

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

227

1.41

1.07

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

105

1.62

1.05

1.8

1.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.71

1.05

4.4

5.0

—

(3013862) HLA-DP [Type]

1.92

1.02

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.89

1.01

2.2

1.2

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

474

1.27

1.01

1.2

11.70

10.49

mm/h

0.26

474

(44806420) Estimation of glomerular filtration rate

139

1195

1.16

1.00

2.3

2.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

136

1169

1.17

0.99

1.4

4.17

4.29

ug/l

0.04

109

1018

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.80

0.98

1.1

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

3.09

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

468

1.26

0.97

2.2

1.8

51.15

355.41

pmol/l

0.91

(3006270) Folate [Moles/volume] in Blood

109

924

1.18

0.95

1.2

377.05

359.62

nmol/l

0.34

766

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

571

1.23

0.91

5.8

5.7

117.86

7782.11

u/ml

0.57

(40758292) HTLV I+II Ab panel - Serum

218

1.38

0.91

1.3

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

339

3105

1.09

0.90

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

143

1.47

0.89

1.2

1.4

—

228.35

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

517

0.77

0.87

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

103

1.55

0.87

1.1

1.2

2.01

1.61

umol/24h

0.95

103

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

144

1.46

0.87

1.7

1.5

—

(3033086) Enterovirus Ab [Titer] in Serum

1.94

0.84

1.0

—

(3033099) Centromere Ab [Titer] in Serum

265

1.32

0.83

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

292

1.30

0.82

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.88

0.81

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.64

0.81

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

500

1.22

0.79

1.9

39.59

40.16

g/l

0.32

500

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.67

0.78

1.0

8.33

8.32

mmol/l

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.53

0.78

1.1

1.0

12.20

13.56

iu/ml

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

403

3747

1.08

0.78

1.8

1.7

6.69

4.48

mg/l

1.49

330

2777

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.77

0.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.77

0.76

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

182

2025

0.90

0.75

1.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.84

0.73

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

263

1.29

0.72

1.3

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1054

0.86

0.71

1.3

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

151

1.39

0.71

1.6

—

(40763791) Oxygen content in Venous blood by calculation

1.92

0.70

8.6

5.8

10.92

11.46

ml/dl

—

(3051101) Glucose [Moles/volume] in Cord blood

182

0.66

0.70

3.3

6.5

12.52

8.27

mmol/l

0.53

182

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.64

0.68

1.3

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

127

1.42

0.67

1.2

60.39

68.45

ug/l

0.31

127

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

284

1.27

0.67

1.1

1.0

0.37

0.88

u/ml

0.74

279

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

119

1.43

0.66

1.1

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.51

0.66

1.1

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

201

2201

0.91

0.64

1.4

1.5

61.74

60.16

ug/l

0.20

161

1828

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.47

0.64

1.7

2.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

243

1.28

0.62

1.1

24.40

19.22

u/ml

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

121

1.41

0.62

1.1

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

170

1869

0.91

0.60

1.5

1.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

188

2055

0.91

0.60

1.4

1.5

0.93

0.95

ratio

0.23

108

1226

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

188

2055

0.91

0.60

1.4

1.5

1.17

1.21

ratio

0.22

108

1233

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

12.30

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

188

2051

0.92

0.58

1.4

1.5

1.16

ratio

0.01

107

1222

(40762887) Creatinine [Moles/volume] in Blood

1.46

0.57

1.5

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

196

1799

1.09

0.57

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

158

1736

0.91

0.57

1.5

1.6

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

107

1.40

0.55

2.3

1.9

60.11

61.97

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.41

0.54

1.1

82.29

94.71

titre

0.30

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

370

3917

0.94

0.52

1.5

1.6

955.36

991.95

mu/l

0.31

301

3293

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

132

1451

0.91

0.50

1.4

1.3

7.52

7.40

mmol/l

0.19

122

1273

(3005033) Fetal Nuchal fold Thickness US

152

1659

0.92

0.50

1.5

1.26

0.06

109

1189

(3023430) Cat dander IgE Ab [Units/volume] in Serum

158

1450

1.09

0.49

1.1

2.79

3.70

u/ml

0.58

633

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.56

0.48

1.1

1.2

209.43

254.59

nmol/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

292

3102

0.94

0.48

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

128

1.33

0.47

1.1

1.0

13.44

6.50

u/ml

1.11

128

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

182

1.26

0.46

1.4

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

182

1.26

0.46

1.4

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

156

1.28

0.45

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

220

1.23

0.43

1.1

14.29

39.79

iu/ml

5.85

220

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.40

0.42

1.0

1.1

37.74

36.62

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.40

0.42

1.0

7.76

8.60

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.40

0.42

1.0

1.1

20.46

21.30

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.1

—

1.25

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.33

0.40

1.1

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

135

1460

0.92

0.39

1.5

57.30

59.91

ug/l

0.27

135

1460

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

142

1.27

0.38

1.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

1.36

0.38

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

159

1704

0.93

0.37

1.9

1.8

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.35

0.37

1.0

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.64

0.35

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

153

1.24

0.35

2.5

2.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

158

1688

0.94

0.35

1.4

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

164

1537

1.07

0.34

1.2

1.1

3.60

3.47

u/ml

0.05

752

(3045683) HLA typing for celiac disease panel - Blood or Tissue

617

0.89

0.34

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

387

1.14

0.33

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

182

1.21

0.33

1.5

1.1

—

(4146454) Self-monitoring of blood glucose

118

1268

0.93

0.32

2.8

2.7

—

(4038314) Semen analysis, post vasectomy

1.32

0.30

1.1

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

343

1.14

0.30

1.4

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.33

0.30

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

419

1.12

0.30

1.1

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

120

1.25

0.30

1.3

1.2

5.97

5.96

mmol/l

0.01

120

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

157

1480

1.06

0.30

2.3

2.1

27.84

25.54

mg/l

0.26

538

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.25

0.29

2.3

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

736

1.09

0.29

1.4

1.3

169.17

177.39

pmol/l

0.18

736

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.23

0.29

1.3

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.25

0.27

1.6

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.28

0.26

1.1

8.73

12.45

u/l

0.52

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

589

1.09

0.24

1.3

5.88

5.83

mmol/l

0.09

558

(40765089) Chromosome analysis panel - Blood by G-banded

284

1.13

0.23

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.28

0.23

1.2

1.1

0.09

0.04

u/ml

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

210

0.86

0.22

2.2

3.1

41.17

44.37

0.27

210

(46235168) Fasting glucose [Moles/volume] in Blood

135

0.81

0.21

1.2

2.9

6.90

7.44

mmol/l

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(40758358) Immune stain study

1.16

0.21

1.0

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

209

0.86

0.21

4.4

6.3

7.17

8.58

0.50

209

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.21

0.0

1.2

—

0.50

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.20

0.0

1.1

—

1280.00

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

1.18

0.19

1.0

1.1

1.27

1.23

mom

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.19

0.18

1.3

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.13

0.17

8.1

8.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.18

0.16

1.0

—

(3011048) Pyruvate [Moles/volume] in Blood

1.14

0.16

1.4

1.2

96.00

84.83

umol/l

—

(3029396) Erythrocyte agglutination [Presence] in Blood

244

1.11

0.16

2.7

2.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

138

1328

1.04

0.16

1.0

1.1

0.09

0.28

u/ml

1.43

437

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.76

0.15

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

800

1.05

0.15

1.0

839.26

738.33

ng/l

0.93

550

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

121

1.16

0.15

1.3

1.2

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

129

0.85

0.14

1.2

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2145

21612

0.99

0.14

3.2

3.3

0.72

0.79

ug/l

2.67

1499

14497

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

369

3618

1.02

0.13

1.7

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

803

1.05

0.13

1.0

32.12

41.95

ng/l

2.54

560

(3001556) Androgen free Index in Serum or Plasma

1.18

0.12

1.4

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

798

1.04

0.11

1.0

270.61

325.40

ng/l

1.58

566

(3002523) Influenza virus A Ag [Presence] in Specimen

190

1858

1.02

0.10

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

190

1859

1.02

0.10

1.2

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

291

1.07

0.09

1.8

1.5

0.47

0.51

e9/l

0.61

291

(3032868) Hemoglobin electrophoresis panel in Blood

1.13

0.09

1.8

1.4

—

(3022475) Manganese [Moles/volume] in Blood

0.77

0.08

1.4

0.13

0.16

umol/l

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.86

0.07

1.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.81

0.07

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.88

0.06

1.1

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

119

1.09

0.06

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

253

2559

0.99

0.05

1.5

1.4

—

(4015189) Microbial culture of sputum

299

1.04

0.03

2.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

350

1.03

0.03

1.1

1.2

500.00

982.89

titre

—

(1761482) Bacteria [#/volume] in Urine by Culture

283

2844

0.99

0.02

5.3

4.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.08

0.02

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

217

0.97

0.01

1.1

—

(3019225) pH of Specimen

1142

11405

1.00

0.01

6.4

4.3

7.36

0.14

924

8138

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

363

1.02

0.01

2.0

1.8

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.06

0.01

1.9

2.3

0.63

ug/l

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

266

0.98

0.00

1.1

69.90

63.98

u/ml

0.14

258

(4133840) Spirometry

284

1.02

0.00

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

436

0.99

0.00

1.4

1.8

0.30

1.85

u/ml

—

119

(40768800) Prostate Pathology biopsy report

241

2416

1.00

0.00

1.3

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

167

1.02

0.00

1.5

1.8

—

(3000285) Sodium [Moles/volume] in Blood

236

1.02

0.00

1.1

1.2

138.47

138.63

mmol/l

0.05

190

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

315

0.98

0.00

1.0

10.75

10.41

u/ml

0.02

210

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.00

-0.00

1.0

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.85

-0.00

1.0

1.1

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.49

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.0

—

288.71

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

248.50

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.0

—

(40760512) CD34 cells/cells in Bone marrow

0.00

-0.00

0.0

2.0

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

460

1.00

-0.00

1.0

1.1

13.70

5.48

u/ml

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

19.20

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

44.57

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.97

-0.00

1.8

1.5

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.89

-0.00

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_SEQUEL_EXTER_CAUSES_MORBIDI_MORTA – Sequelae of external causes of morbidity and mortality

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Sequelae of external causes of morbidity and mortality

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Sequelae of external causes of morbidity and mortality (VWXY20_SEQUEL_EXTER_CAUSES_MORBIDI_MORTA)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints